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Cancer is a disease characterized by accelerated cell growth, resulting in healthy tissue being 
destroyed by the processes of invasion and metastasis. Non-viral gene delivery approaches have been 
extensively studied as a basic tool for intracellular gene transfer and gene therapy especially for 
genetic aberrations including cancer. Gold nanoparticles have attracted strong biomedical interest for 
drug delivery due to their low toxic nature, surface plasmon resonance and capability of increasing 
the stability of the payload. In the present study the synthesis of photoluminescent nanoparticles 
consisting of a gold core coated with polyethyleneimine, poly-L-lysine, cysteine and chitosan is 
reported. These functionalized gold nanoparticles (FAuNPs) were investigated at different pH values 
and ionic strength to identify the optimum conditions to produce stable monodisperse nanoparticles. 
FAuNPs showed good stability at low ionic strength which is important for the flexibility of the 
polymer chain. All nanoparticle/polymer formulations remained in the size range 11.9-195 nm with 
narrow particle distributions and low PDI (<1.2). TEM images revealed nanoparticles that were 
spherical and monodispersed. Nanoparticle and pDNA complexation was efficiently demonstrated in 
the band shift and ethidium bromide intercalation assays respectively. The serum nuclease digestion 
assay revealed that the nanoparticles provided partial protection to the complexed plasmid DNA 
(pCMV-luc). MTT cytotoxicity experiments indicated that the FAuNPs elicited a dose dependent 
cytotoxic effect with the four mammalian cell lines (HepG2, HEK293, HeLa and Caco2) tested 
responding differently. Au-PEI/pDNA maintained over 80% cell viability across all cell lines, while 
the Au-cys/pDNA exhibited a significant 91.8% (p<0.001) in Caco2 cells, Au-Chit/pDNA 126% 
(p<0.01) in HepG2 cells and Au-PLL/pDNA 104% in Hela cells. Transfection studies were 
accomplished using the luciferase reporter gene assay. Results showed that the FAuNPs produced 
greater transgene activity than the cationic polymer/DNA complexes on their own. This was evident 
for the Au-PEI/pDNA complex which produced a 12 fold increase in the HEK293 cells and a 9 fold 
increase in the HepG2 cells, compared to the PEI/pDNA complexes alone. The results of this study 
suggest that FAuNPs low cytotoxicity coupled with the ability to parametrically control particle size 
and surface properties, make these nanoparticles suitable non-viral gene delivery vectors. However 
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Introduction and literature review    
1.1 The beginning of gene therapy  
Gene therapy has captured the attention of many researchers and medical practitioners in the 
scientific community. The perception that this approach can treat diseases by delivering 
exogenous DNA into the nuclei of target cells to express a therapeutic protein was first proposed 
in 1972 (Kim et al., 2013). It is based on the transfer and expression of therapeutic genes in 
specific target cells (Mohr and Geissler, 2002). Although gene therapy sounds like a new and 
innovative field of research, the transfer of genetic material into living cells has been around for 
decades. However, this field is still in need of becoming an acceptable treatment as a cure for 
human diseases even though it has established therapeutic applications in infectious diseases, 
cancer and degenerative disorders. Each successful trial holds the prospect of successful 
treatment making it more feasible. Various examples of gene therapeutics include iron oxide 
nanoparticles, amino-modified silica nanoparticles, carbon nanotubes and gold nanoparticles 
(Kneur et al., 2000; Xiang et al., 2003; Bianco et al., 2005 and Sandhu et al., 2002). The 
significance of nucleic acid delivery for disease treatment is echoed in an abundance of clinical 
trials in scientific literature, with the approach being to transfect cells with plasmid DNA that are 
designed to replace a defective gene in the target cell genome.  
Gene therapy trials have been implemented worldwide over the past twenty years, however, little 
progress has been made in curing diseases because a number of major steps must be overcome 
for successful clinical applications. Gene therapy must not only improve and enhance gene 
transfer but also gene expression. An ideal gene delivery system should be non-toxic, non-
immunogenic, biodegradable, stable, accessible and suitable for efficient gene expression. A 
model system should meet three important criteria. Firstly, it should protect the therapeutic gene 
against degradation by nucleases in intercellular matrices, secondly it should transport the 
therapeutic gene (transgene) across the plasma membrane and into the nucleus of target cells and 





acids using carriers such as polymeric micelles, dendrimers, nanotubes or nanoparticles (NPs) 
has attracted increasing attention as a consequence of the low feasibility, stability, ease of large-
scale production and lack of immunogenicity that characterize some of these nanomaterials 
(Cebrian et al., 2011; Luo and Saltzman, 2000a; Pouton and Seymour, 2001 and Gemeinhart et 
al., 2000).  Many possible vectors are under intense scientific investigation (Godbey, 1999.) Two 
classes of vectors proposed for gene delivery are the viral and non-viral vectors which differ in 
their assembling processes. Viral dependent methods such as the retrovirus, adenovirus, adeno-
associated virus and other viral vectors are still popular methods of gene delivery. They are 
assembled in the cell and are replication-defective viruses that have over the years presented 
many safety issues leading to the emergence of a variety of non-viral gene delivery vehicle 
approaches (Kim et al., 1993). Although the use of viruses for gene therapy is highly effective in 
terms of its ease and feasibility, there are certain shortcomings associated with its practical use 
such as insufficient viral titers, toxicity and the potential replication of competent viruses which 
may result in lower efficacy in gene transfer and gene expression. (Huang et al., 1999). Viral 
vectors have boundaries and therefore make synthetic vectors an attractive alternative. The 
successful system should selectively and competently deliver genetic material, with the ultimate 
goal being to cure inherited and acquired disorders and eliminating their causes, by adding, 
correcting or replacing genes (Mohr and Geissler, 2002).  
Non-viral approaches have also been extensively studied for intracellular gene transfer and gene 
therapy and have an advantage over viral vectors due to their feasibility of being produced on a 
large scale, simplicity and low toxicity (Huang et al., 1999). Liposomal assimilation into 
nanoparticles is preferred because of decreased side effects and prolonged drug exposure due to 
slow release. These are known as second and third generation carriers with ligands. The most 
important factors for applicability of the nanoparticle include particle sizes, particle surface 
functionalities and solubility in the desired media. At the nanoscale, the increase in the surface 
area to volume ratio is an exclusive phenomenon as it alters the mechanical, thermal and 
catalytic properties of the material. There is a still a need for better gene transfer technology, and 
its application holds possibilities for great developments in how we manage ailments today. It is 





the endosome and delivery of the nucleic acid to the nucleus will provide us with vital signs 
towards improved designs of non-viral vectors that can evade viral-associated disadvantages. 
The need to understand endocytic pathways has never been more critical due to an increasing 
number of nanosized drug carriers (liposomes, nanoparticles and viral vectors), macromolecule 
drugs (proteins, oligonucleotides and synthetic polymers) and macromolecular conjugates (of 
polymers, proteins and antibodies) in research and development (Figure 1.1). A further benefit of 
the use of nanoparticles as non-viral vectors for gene delivery in vitro comes from their ability to 
sediment on the surface of target cells, which accelerates the transfer of biomolecules 












Figure 1.1: The assembling of nanoparticles with different material compositions and different physical 






1.2 Emerging trends in nanotechnology  
Nanotechnology has emerged with new materials and products altering many aspects of our lives 
and generating international interest by academics and industrialists. It deals with nanoscale 
materials (1-100 nanometers) by developing novel technologies to probe and manipulate single 
atoms and molecules. A nanoparticle behaves as a whole unit in terms of its transport and 
properties and their small size allows them to penetrate cells and tissues. Materials at the 
nanoscale level often exhibit very different and desirable physical, chemical, and biological 
properties compared to their normal sized counterparts. These same properties may also 
contribute to their toxicity and to their ability to produce adverse side effects. Subsequently, 
countries and international organizations have raised safety concerns over the applications and 
exposure to these nanoparticles. The Organization for Economic Cooperation and Development 
(OECD), an inter-governmental organization, is an organization that plays a critical global role 
in ensuring that emerging technologies, including nanotechnology, are developed responsibly 
(Murashov et al., 2011). A large range of materials with distinct properties are found in 
sunscreens, cosmetics, paint, remediation, water purification, batteries, lubricants, medical 
equipment and drug delivery treatments. Nanotechnology may help in transporting drugs across 
the blood brain barrier. Researchers have been building liposomes loaded with nanoparticles to 
gain access through the blood brain barrier. This new field is still being explored and holds 
promise for the application of nanotechnology in clinical neuroscience for treatment of disorders 
such as Alzheimer’s and Parkinson’s disease. Delivering drugs across the blood brain barrier is 
one of the most promising applications of nanotechnology in neuroscience. In essence 
nanoparticles could potentially carry out multiple tasks in a predetermined sequence, which is 
significant in the distribution of drugs across the blood brain barrier (Brigger et al., 2002).  
1.3 Cancer and associated diseases 
Cancer is a serious disease in developing countries and is fast becoming the prime cause of death 
in industrialized counties as well. It is defined as a disease that causes uncontrollable growth of 
dysfunctional cells due to its aggressive growth profile. The distribution of a primary tumor to an 
anatomical site is defined as cancer metastasis. It remains a major challenge and cause of 





play a crucial role in the growth and progression of cancer (Weir et al., 2004). Tumors require a 
relatively short expression of therapeutically active proteins, whilst monogenic diseases such as 
cystic fibrosis need long term expression (Anson et al., 2006). Four important targets have to be 
achieved by vectors in cancer gene therapy, viz. oncogene expression must be turned off, tumor 
suppressor expression must be enhanced to induce apoptosis of cancer cells, neo-angiogenesis 
must be inhibited and the immune system must be stimulated against the tumor cells (Morille et 
al., 2008). The near infrared (NIR) laser in the region of 650-1000 nm has attracted increased 
attention as NIR laser irradiation can induce hyperthermia damage of cancer cells and tumors 
with deep tissue penetration and skin absorbance. In order to exploit new strategies for treatment 
of metastatic cancers, new avenues for efficient management are highly desired. Statistics reveal 
that head and neck carcinoma is the 6th most common cancer worldwide (Wang et al., 2014). 
Approximately 600 000 new cases are reported yearly. Revealing a mortality rate of 50%, 
squamous cell carcinoma of the oral cavity accounts for close to 389 000 cases per year. 
Standard treatment such as radiation therapy, surgery and chemotherapy are effective but may 
cause significant side effects in patients. Often times this treatment is found to be ineffective due 
to infiltrating and progressive tumors. Surgical operations on squamous cell carcinoma cause 
unnecessary damage to adjacent or underlying anatomical structures, while radiotherapy can lead 
to complications such as osteoradionecrosis, soft tissue necrosis or spinal cord myelitis. 
Although there has been recent advances in modality therapy, the overall 5 year survival rate of 
patients with head and neck squamous cell carcinoma remains at 40-50%. Cancer research UK 
reported that prostate cancer is the fourth most common form of cancer in the country, with 40 
841 new cases reported since 2009 (http://www.wired.co.uk, Accessed 31 October 2014). 
Therefore there is an urgent need to develop non-invasive methods with fewer side effects to 
treat patients suffering from cancer.  
1.4 Mechanisms of gene delivery 
Popular methods of transfection employed over the years include chemical or physical methods 
by calcium phosphate precipitation, electroporation, microinjection, and liposomal transfer. Non-





delivery systems are required to promote targeted delivery of peptides, oligonucleotides and 
proteins to specific intracellular compartments. Non-targeted gene delivery methods would non-
specifically deliver genes to all cells exposed to the delivery vehicle (Kim et al., 1993). 
Macromolecular therapeutics and nanosized delivery systems are generally taken up by the 
process of endocytosis. Following internalization via ligand-stimulated cellular pathways such as 
clathrin-coated pits and membrane mechanisms, intracellular trafficking can lead to rapid 
removal out of the cell (5-10 min), trancytotic passage across an epithelial barrier, 
lysosomotropic delivery (30 minutes-1 hour) or delivery to the Golgi network. Physical 
approaches (carrier-free gene delivery) and chemical approaches (synthetic vector-based gene 
delivery have been explored. Physical approaches include needle injection (Wolff et al., 1990) 
electroporation (Heller et al., 2005 and Neumann et al., 1982), gene gun (Yang et al., 1990 and 
Yang et al., 1995), hydrodynamic delivery (Liu et al., 1999 and Zhang et al., 1999) and 
ultrasound (Lawrie et al., 2000).  
1.5 Mechanical methods 
There are several mechanical means of transfection and the three commonly employed are 
discussed below. 
1.5.1 Microinjection  
The direct injection of nuclei is perhaps the most simple, with respect to its practicality and has 
the advantage of not exposing DNA to the cellular compartments where degradation may occur. 
The drawback is that microinjection can be achieved only on a small scale i.e. one cell at a time 
which limits its use to applications in which individual cell manipulation is desired resulting in 
low levels of gene expression (Gao et al., 2007). Though relatively efficient, this method is also 
laborious (Luo and Saltzman, 2000a). A pressure mediated naked oligonucleotide transfection 
method using controlled non-distending pressure was developed by Mann and colleagues (1999), 
and showed gene delivery efficiency of greater than 50% in cardiovascular tissue. Naked DNA-
mediated gene delivery may not be conceivable because DNA is large in size and highly 





endothelium, interstitial matrices, the mucus lining, tightly specialized junctions of epithelial 
cells and the plasma membrane of all cells. Nucleases further reduce the chance that DNA 
eventually entering the nuclei will be intact and functional. Physical approaches can induce 
injuries and defects on cell membranes so that DNA can enter the cell by diffusion.  
1.5.2 Gene gun method 
Particle bombardment also called the biolistic particle delivery through a gene gun is an ideal 
method for gene transfer to skin, mucosa or surgically exposed tissue within a confined area 
(Yang et al., 1990). It uses a high pressure helium gas surge to accelerate the cargo and deliver it 
into the cell. It was first described by Klein et al. in 1987 and used primarily to transfect plant 
cells. Due to the focus being on the DNA transfection efficiency, the fate and the localization has 
not been reported. This method has been used to transfer nanosensors into several adherent cells 
lines and the cells displayed a good nuclear uptake of the nanosensor according to the 
fluorescence levels and distribution as measured by confocal microscopy (Webster et al., 2007). 
DNA coated on the surface of gold nanoparticles are fast-tracked by pressurized gas at high 
velocity, to penetrate a few millimeters into cell membranes and release DNA into cells (Gao, et 
al., 2007; Yang et al., 1990 and Yang and Sun., 1995). Bombardment is widely employed in 
DNA vaccination where limited local expression of delivered DNA is adequate to achieve 
immune responses (Luo et al., 2000b). Further improvements could include chemical 
modifications on the surface of the gold particles to allow greater capacity and better stability for 
DNA binding and adjustment of the expelling force, for precise control of DNA deposition into 
cells in various tissues (Green and O’Brian et al., 2000).   
1.5.3 Electroporation 
High voltage electric pulses to mammalian cells lead to the formation of nanometer-size pores in 
the plasma membrane. This approach permits cellular uptake of macromolecules and was first 
used to deliver DNA to mammalian cells in 1982 (Wong et al., 1997 and Neumann et al., 1982). 
DNA enters the cytoplasm of the cell through the pores as a consequence of the redistribution of 





Electroporation has also been tested in several in vivo studies including the cornea, skin, 
endothelium and muscle (Banga et al., 1998; Oshima et al., 1998 and Alhara et al., 1998). 
Rizzuto and colleagues (1999) used low voltage, high-frequency electric pulses to promote DNA 
uptake in muscle with only transient tissue damage. Gene transfer by electroporation showed less 
variation in efficiency across species sing direct DNA injection. Previous research demonstrated 
that electroporation increased transgene expression in isolated lung ex vivo organ culture 
showing that it also worked in live animals (Gao et al., 2007). Single electroporation has 
produced long term expression that lasted for a year. Contributing factors to the efficacy of this 
method firstly include the amount of DNA and how well the injected plasmid DNA distributes 
within the treated tissue, and secondly the age of the recipient animal. Electroporation has been 
used to deliver DNA to a myriad of cell types in vitro including yeast and bacteria (Luo and 
Saltzman., 2000a). It is one of the most efficient gene transfer methods but is limited because of 
its high mortality of cells after high-voltage exposure and difficulty in optimization (Luo et al., 
2000a).  
1.6 The history of gold nanoparticles 
Dating back to the Middle Ages, base metals were converted into gold by using the philosophers’ 
stone. The foundation of modern chemistry was laid by discovering the physical and chemical 
properties of the substances used (Kauffman, 1985). In the early 16th century alchemists focused 
on making gold drinkable which they believed would promote therapeutic applications. Women 
of royalty drank gold to add to the lustre of their beauty and youth. It was later found that when 
they died the gold was precipitated out into their hair creating strands of gold. The most common 
form of gold in artwork and decorative forms is the stained glass in numerous churches. Glass 
that shows a translucent ruby red colour in transmitted light and green colour in reflected light is 
due to the presence of gold colloids (Freestone et al., 2007). At the dawn of the 18th century, 
gold was being employed in the treatment of syphilis and scrofula (Higby, 1982). In the late 90’s 
gold sodium thimalate (Myochrysine) and gold thioglucose (Solgonal) were being used in the 
management of rheumatoid arthritis (Shaw, 1999). Currently a new glycopolymer mimicking the 
thiosugar ligand of the gold-based drug auronofin was designed (Pearson, 2015). Certain cultures 





giving properties. Gold was seen as the earthly form of the sun and healers including religious 
believers from the east created jewellery that protected the wearer from the evil eye. Gold has a 
melting point of 1064 C and it is the noblest of the metals because of its resistance to surface 
oxidation. Scientists have proven in some cases that gold does not obey quantum chemistry nor 
classical laws of physics (Higby, 1982). 
1.6.1 Unique properties of gold nanoparticles in biomedical applications 
Among the candidate nanomaterials, gold nanoparticles have emerged as therapeutic resolutions 
on account of their intrinsic properties and also because of their ease of synthesis and chemical 
functionalization of their surface (Ghosh et al., 2008 and Krishna et al., 2011). They can be 
easily functionalized by anchoring a thiol linker in their monolayers. A wide variety of 
functional bio-nanoconjugates have been obtained, including nanoparticles modified with 
peptides, proteins, antibodies, oligosaccharides and nucleic acids. This allows the nanomaterials 
to act as multifunctional platforms for both therapeutic and diagnostic purposes. To attain proper 
cellular applications using nanomaterials, it is critical not only to achieve efficient delivery to 
healthy cells but also to control the intracellular availability and the fate of the nanomaterial. 
When introduced into the body, nanostructures will at some level evoke a response from the 
body's protective machinery, primarily the immune system. Thus, the final goal of targeted 
nanostructures, can only be realized when we find ways to overcome or avoid these protective 
mechanisms. Using knowledge of physiologic, anatomic, and immunologic constraints combined 
with carefully designed nanomaterials of appropriate size and surface characteristics, gold 
nanoparticles have the potential to provide effective strategies for the development of effective, 
targeted gene/drug delivery (Papasani et al., 2012). 
In nanoscience and nanotechnology today, gold nanomaterials appear to be the most widely 
studied and used of all materials by both academics and industrialists. These nanoparticles are 
also synthesized with remarkable structural diversity, such as spheres, rods, wires, stars etc., with 
each structure exhibiting their own individual characteristics. Their potential application in 
cellular imaging (Murphy et al., 2008) is due to their light scattering properties such as strong 





optical microscopic imaging of cancer cells. They are bio-inert, non-toxic and readily 
synthesized (Daniel et al., 2004), and their small size allows them to penetrate cells and tissues, 
making their application in medicine far reaching. They have become accepted as 
radiosensitizers in radiotherapy, because of their unique size and shape dependent optical 
properties and high extinction coefficient. The secondary electron caused by gamma or x-ray 
irradiation can accelerate DNA strand break (Zhang et al., 2012). Gold nanoparticles, 
particularly gold nanorods, have shown promise owing to their strong absorption in the NIR 
“optical window” for biological samples. They have been used to ablate tumors located deep 
inside body tissues (Dickerson et al., 2008; Choi et al., 2011 and von Maltzahn et al., 2009). The 
treatment involves introducing radioactive gold nanoparticles directly to a tumor causing it to 















Figure 1.2: Types of functionalization of gold nanoparticles and their potential biomedical applications. 






According to Sandra Axiak-Bechtel, an Assistant Professor of oncology at the University of 
Missouri (MU) College of Veterinary Medicine, gold nanoparticle prostate cancer treatment was 
found safe in dogs, (MU News Bureau) as gold nanoparticles have the potential to “tag” 
cancerous cells. This is due to coating of nanoparticles with imaging reagents before being 
introduced to brain tumor patients. The gold spheres drained out of the tiny blood vessels and 
lodged in nearby tumor material. Here the coated particles were selected using MRI, 
photoacoustic and Raman imaging, and used as a map for the brain tumors. AuNPs absorb and 
resonantly scatter visible and near-infrared light upon excitation of their plasmon oscillation. The 
photo-physical properties of gold nanoparticles can be exploited in ways that control the 
transport and release of drugs. Drugs can be released from a gold nanoparticle via internal 
stimuli that is operated by biologically controlled factors such as pH or glutathione or via 
external stimuli operated with the aid of stimuli-generating processes such as the application of 
light (Pissuwan et al., 2011). AuNPs have also been utilized in gene guns where the AuNP was 
coated with DNA and transferred to a mylar carrier sheet (Yang et al., 1990; Andree et al., 1994 
and Sun et al., 1995). An electric arc generated by a high-voltage discharge, accelerated the 
nanocomplex to high velocities which enabled efficient penetration of target organs in vivo or 
single layers in vitro.  
On a larger scale i.e. in its bulk form, gold is yellowish. It attained its noble status compared to 
other metals because it is resistant to surface oxidation. Gold nanoparticles have different 
properties to bulk molecules which render them attractive for medical purposes. Their 
importance is based on their surface to mass ratio that is larger than that of other particles. 
Furthermore, their quantum properties and their absorption abilities allow them to carry 
compounds such as drugs, probes and proteins. AuNPs hold promise in diagnostics and therapy, 
and are fast becoming one of the most popular nanomaterials worldwide. This can also be 
attributed to their extraordinary magnetic, optical and catalytic properties. There are a number of 
structural variations that can produce AuNPs in the form of rods, spheres, stars, wires and 
ribbons. Their industrial application is far reaching in terms of chemical processing, control of 





(McPherson and Thompson, 2009a). AuNPs offer possible suitable delivery mechanisms for 
gene therapy. DNA adsorption is maximized by the chemical modification of gold nanoparticles 
(Cebrian et al., 2011). Cationic capping favours high-affinity electrostatic interactions with 
nucleic acids to ensure efficient binding and gene delivery to mammalian cells. It has been 
investigated and confirmed that the toxicity of gold nanoparticles in cancer treatment could be 
minimized by using less AuNPs, while exhibiting increased treatment efficiency. Rifampicin-
conjugated gold nanoparticles greatly enhanced the rate as well as the efficiency of the 
accumulation of anticancer drugs bound to nanoparticles, and consequently their concentration 
inside the cancer cell. Cell viability results showed an impressive enhancement in the 
photothermal therapeutic effects of gold nanorods in the presence of rifampicin (Ali et al., 2014).  
1.7 The importance of gold nanoparticles in gene delivery 
Gold nanoparticles (AuNPs) have attracted strong biomedical interest for drug delivery, due to 
their low toxic nature, surface plasmon resonance and capability of increasing the stability of the 
payload. Gene transfection represents yet another important biological application. Considering 
that cellular barriers keep enclosed their secret to deliver genes using nanoparticles, an important 
step can be achieved by studying the functionalization of gold nanoparticles because gold 
nanoparticles, by themselves, do not have target recognition abilities necessary for selective 
binding of analytes. In order to selectively detect analytes of interest, antibodies, proteins, short-
chain organic acids, amine-thiols, or DNA, molecules have been used to modify the surface 
properties of AuNPs to provide target recognition sites (Daniel et al., 2004 and Rosi et al., 
2005). This includes the delivery of drugs and of biomolecules such as peptides, proteins, and 
nucleic acids, and also for photo-thermal therapies. Major strides have been made towards the 
development of carrier systems based on gold nanoparticles. Current research shows that they 
can be functionalized and engineered using targeting ligands to accumulate in tumor cells for 
biological and biomedical applications including therapeutics, diagnostics, bio-imaging and bio-
sensing (Ghosh et al., 2008b). Figure 1.3 depicts the functionalization and various applications 
of AuNPs in gene and drug delivery.  Prototypes have been in place in many areas of research, 














Figure 1.3: Various applications of gold nanoparticles in therapy indicating applications such as gene 
delivery, drug delivery, photothermal therapy and targeting. Adapted from Ghosh et al., 2008b.  
Currently the field of particle-based drug delivery is focused on two chemically distinct colloidal 
particles, liposomes and biodegradable polymers (Muller et al., 2000; Jain et al., 1998; Ogawa, 
1997 and Maruyama et al., 1998). These delivery systems can both encapsulate the active drug. 
In the case of liposomes, the drug is released from the particle as it lyses or it disintegrates 
similar to biodegradable polymers. Motivated by their relative non-toxicity and biocompatibility 
which are important in delivery applications, colloidal gold nanoparticles have been used for 
targeting cancerous cells in vivo, which is comparable to conventional diagnostic dyes that are 
known to be susceptible to photobleaching (Jain et al., 1998). Cationic gold nanoparticles 
prepared by the NaBH4 reduction in the presence of 2-aminoethaethiol were shown to form a 
complex structure with plasmid DNA containing a luciferase gene, and was able to deliver this 
gene to the target HeLa cells within 3 hours (Niidome et al., 2004). The electrostatic binding of 
siRNA to gold nanorods by conjugation of cetyltrimethylammonium bromide (CTAB) gold 
nanorods to the siRNA (against DARPP-32 gene in dopaminergic neuronal (DAN) cells) and the 





nanoparticles can be used as innovative vehicles to deliver genes into neuronal cells and could 
provide the basis for nanotherapy to treat drug addiction in patients (Bonoiu et al., 2009). The 
combination of phototherapy with conventional gene therapy offers great possibilities to improve 
the dexterity of gene delivery into cells (Mariko et al., 2005).  
1.7.1. Surface plasmon resonance of gold nanoparticles  
The allure and fascination of AuNPS since the ancient times originates from their photophysical 
properties such as their intense colour. With regard to shape as a function of efficacy, the surface 
plasmon resonance (SPR) of gold nanostructures can be adjusted in the visible and near infrared 
region (Murphy et al., 2005; Sau et al., 2004a; Sau et al., 2004b, Nikoobakht et al., 2003). This 
phenomenon is termed surface plasmon resonance and can be explained as follows. On exposure 
to light the oscillating electromagnetic field of a metal particle induces a collective coherent 
oscillation of the free electrons of the metal. The electron oscillation around the particle surface 
causes a charge separation with respect to the ionic lattice. This forms a dipole oscillation along 
the direction of the electric field of the light. The amplitude of the oscillation reaches a 
maximum at a specific frequency and induces a strong absorption of the incident light which can 
be absorbed using a UV-visible absorption spectrophotometer. SPR bands are affected by 
particle size, shape, composition, structure and the type of the metal. As theory states, gold 
nanorods exhibit two SPR bands, the transverse band and longitudinal band that correspond to 
the oscillation of electrons along the short and long axis of the nanorod respectively. By 
increasing the aspect ratio of gold nanorods the longitudinal band can be adjusted from the 
visible to the NIR region causing a localized hypothermic effect that can be used in therapeutic 
applications (Gorov et al., 2007; Jain et al., 2007; Kattumuri et al., 2007; Durr et al., 2007; Kim 
et al., 2007; Eghtedari et al., 2007; Huang et al., 2007).  
1.7.2 Surface charge and zeta potential 
Molecules that have been used to modify the surface properties of AuNPs can be incorporated 
into AuNPs through electrostatic attraction or covalent bonding. It is an effective way to enhance 





be successfully utilized in medical applications their fundamental properties such as the forces 
that are responsible for nanoparticle-drug stabilization must be clearly understood. It is essential 
that the electrokinetic characterization be studied at the outset, because in order to design an 
ideal carrier, one needs to know the features and properties of the system that one is working 
with. These include hydrophobicity/hydrophilicity, size and most importantly charge. It is 
important to note that each time the surface of a nanoparticle is functionalized, any one of these 
(or all three at the same time) properties may change. Adsorption on the surface, commonly 
results in a modification of the charge. Therefore electrophoretic mobility (Ue) analysis 
determines and optimizes the preparation conditions of the final surface charge. Complementary 
to this feature, dynamic light scattering must also be performed in order to confirm the surface 
modification of the nanoparticle with an external agent. Size and surface charge of DNA 
complexes are two important factors in determining the efficiency of cellular uptake. Although 
there is a common theme in all vectors, each vector has to be suitably tailored and optimized to 
meet the needs of a specific application.  
Zeta potential is the term given for the electrokinetic potential in a colloidal dispersion. It is the 
electrical potential at the slipping plane. This net electrical charge can be generated through the 
ionization of a surface functional group on the colloid, ion adsorption or by the ion dissolution of 
the colloid material bound by the slipping plane. This is largely dependent on the location of the 
plane. Zeta potential is often the only available path for characterization of the double layer 
(Caruso, 2004). Counter ions closest to the charged wall surface are strongly bound to the 
surface, forming what is called the stern layer. Adjacent to the stern layer, is the diffuse layer that 
contains loosely mobile ions. It is within this diffuse layer that there is an imaginary boundary 
where the ions and particles attain a stable form. This boundary is called the slipping plane 
(Figure 1.4). This is an extremely important parameter in the theory of interaction of particles 
(Caruso, 2004). The electrical potential of the double layer decreases as a reciprocal function of 
the distance from the particle and approaches zero as the counter ions gradually reduce the effect 
of the field created by the surface. If all the particles in suspension have a large negative or 
positive zeta potential then they will tend to repel each other and this will reduce the tendency 





will be no force to prevent the particles from aggregating. The dividing line between stable and 
unstable suspensions is either +30 or -30mV. Two important contributing factors that affect zeta 
potential are pH and conductivity. With regards to pH, one has to define the solution conditions, 
since addition of an acid to a suspension will cause the particles to acquire positive charge whilst 
if more alkali is added then the particles tend to acquire more negative charge (Jada and Salou, 
2002). Conductivity is the ionic strength of a medium and is the second contributing factor. The 
higher the ionic strength, the more compressed the double layer becomes (Lyklema, 1998 and 
Bikerman, 1940). The double layer thickness is also influenced by the valency of the ions. A 
trivalent ion such as Fe3+ will compress the double layer to a greater extent than a monovalent 
ion such as K+. At low concentrations the specific adsorption of ions onto a particle surface can 
have a dramatic effect on the zeta potential of the particle dispersion. Specific ion adsorption 
















    
















Figure 1.4: Diagram of zeta potential and slipping plane showing the ionic concentration and potential 
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1.7.3 Dynamic light scattering  
Dynamic light scattering is the method of measuring the size distribution profile and the level of 
aggregation in gold nanoparticles. Particles in a colloid solution follow Brownian motion as a 
result of continuing particle collisions and movement. Based on Brownian motion, smaller 
particles will move quicker. A laser passing through the colloid will disperse, and the intensity of 
the dispersed light is dependent on the movement of the colloid particles. Hence particle size can 
be determined using the Stokes-Einstein relationship. Zeta potential is a powerful tool that is 
used to analyze the electrostatic forces within the bulk solution and on the surface of the 
nanoparticles and nanocomplexes, respectively (Rodríguez-Pulido et al., 2009). Zeta potentials 
are calculated by applying the Smoluchowski model analysis based on the laser-Doppler micro-
electrophoresis technique. There are many methods to determine the dimensions of 
nanoparticles. Some methods are direct like microscopy and others use relationships such as 
diffraction. Light scattering occurs when photon energy causes electron oscillations in the matter 
which emits photons in the form of scattered light. If this is at the same frequency, the incident 
light is known as Raleigh scattering or if it is at a shifted frequency it is called Raman scattering. 
The light absorption and scattering are strongly enhanced due to its SPR oscillation. This takes 
place at a rate of 5-6 orders of magnitude stronger than most strongly absorbing organic dye 
molecules and the emission obtained the same as that of the most strongly fluorescent molecules. 
The ratio of the scattering to absorption increases dramatically for larger sized particles. For 
imaging, larger nanoparticles are preferred because of higher scattering efficiency whilst for 
photothermal therapy smaller nanoparticles are preferred as light is mainly adsorbed by the 
particles. Gold nanoparticles possess non-radiative properties by converting the absorbed light 
into heat via a series of non-radiative processes. This has been extensively studied by the El-
Sayed group (2005).  
 
1.8 Characterization of gold nanoparticles for gene delivery  
1.8.1 Synthesis of nanoparticles  
Synthesis of nanoparticles must be done in a manner that produces the required size, shape, 





and Miyake, 1998 and Watzky and Finke, 1997). In a two phase reaction, formation of ruby red 
colloidal gold solutions were observed by reducing gold salts with phosphorous in carbon 
disulfide. Colour changes were reported upon compression in the interactions of light and thin 
films of dried colloids. A description of the leading three methods; citrate-reduction, polyol 
method and the two-phase Brus-Schriffin (1984) are as follows. 
1.8.1.1 Citrate reduction method 
This is one of the most broadly used methods for manufacturing colloidal gold nanoparticles. It 
is both simple and scalable, and provides for the large scale production of colloidal gold 
nanoparticles. Gold nanoparticles with varying core sizes prepared by the reduction of 
chloroauric acid (Au+3, HAuCl4) to neutral gold (Au0) by agents such as sodium citrate (Frens, 
1972) (Figure 1.5). The addition of sodium citrate to the gold chloride initiates a series of well-
described reduction reactions characterized by changes in the colour of the initial gold chloride 
solution (Frens, 1973). There has been vast interest in the study of the citrate-capped gold 
nanoparticle evolution of the colour changes. The colour changes range from pale yellow, 
colourless, dark blue, purple to ruby-red. The initial transition from dark blue to red on reduction 
of the gold (III) by citrate is associated with a decrease in particle size. The large particles are 
generally spherical in shape with a size range of 100-200 nm, while the smaller well-defined 
subunits range from 5-15 nm in size. The formation of small nanoclusters (5 nm) is a result of 
gold atoms that undergo nucleation. These nanoclusters assemble in a linear-like fashion into an 
extensive network of nanowires (Pan et al., 2007). The diameter of the nanowires is increased 
when more gold adsorbs leading to destabilization. The wires then undergo fragmentation and 




Figure 1.5: The characterization of gold nanoparticles by the reduction of sodium citrate. Adapted from 





1.8.1.2 Polyol reduction method  
This method that has also gained popularity, involves the reduction of the metal salt in the 
presence of a protecting polymer usually polyvinyl pyrolidone (PVP). It was developed by Fievet 
and coworkers and entails refluxing the metal precursors (oxides, nitrates and acetates) in 
ethylene glycol or polyols (polyethyelene glycol) (PEG) in the presence of a polymer for a 
specific period of time (Fievet et al., 1989). Therefore it is known as the polyol method. 
Investigations into the reaction mechanism revealed a solution based reduction pathway. This 
means that the nanoparticles are formed by nucleation and growth from the solution, with polyol 
acting as a solvent for the inorganic compound due to its high dielectric constant. Gold 
nanoparticles prepared via the polyol method demonstrated a pH dependent particle size effect, 
where an increase in particle size is associated with a rise in pH. Generally the use of the polyol 
is advantageous in that the glycol is adsorbed onto the nanoparticle surface, minimizing particle 
surface oxidation.  
1.8.1.3 Two-phase reduction: Brust-schiffrin method  
The use of alkanethiolates of different chain lengths can be used as capping agents for gold 
nanoparticles (Giersig and Mulvaney, 1993). The method developed by Brust and coworkers in 
1994 has gained immense popularity in gold nanoparticle synthesis (Brust et al., 1994). It is a 
two-phase redox reaction that involves dissolving AuCl4- in water, and the transfer of AuCl4- into 
a toluene layer by the action of a phase-transfer reagent, tetraocytylammonium bromide 
(TOABr). A one-phase reaction has also been reported as a modification of the two-phase 
protocol (Alivisatos, 1996). Since the advent of this study, a wide range of research has gone into 
developing other suitable capping ligands which include thiols-, amine-, silane-, phosphine and 
disulfide-based capping ligands (Weisbecker et al., 1996; Green and O’Brien, 2000; Prasad et 
al., 2003). Particles of sizes ranging from 1-10 nm could be synthesized by varying the 
stabilizer/gold ratio. The nanoparticle synthesized by this method showed tremendous stability. 
They could be dried and treated as simple chemical powders and re-dispersed in solvents as 





1.8.2 Stabilization of gold nanoparticles  
The first synthesis of gold colloids was reported 150 years ago when Michael Faraday used 
phosphorous to reduce AuCl4- ions (Yang et al., 2007). Since then numerous procedures have 
been proposed to synthesise AuNPs of different sizes, and shapes, and in different dispersion 
media depending on the application (Rossi, 2006 and Durcan et al., 2008). Aqueous dispersions 
are the most common preparation method for biomedical applications. The most common and 
simplest method is the citrate reduction technique which was introduced by Turkevich in 1951, 
via reduction of hydrogen tetracholoaurate (HAuCl4) in boiling sodium citrate. It was also 
reported that nanosized AuNPs from 15 to 150 nm could be obtained through an adequate 
control of the ratio of trisodium citrate to HAuCl4, with higher ratios yielding smaller particles 
(Frens, 1973; Handley, 1989). The citrate ions have dual functions, in that they act as reducing 
agents to reduce Au+3 to Au0, and  they also act as stabilizing agents by forming a layer of citrate 
anions on top of the nanoparticle surface which repels the particles from contacting each other 
and thus preventing the aggregation of the particles. The main differences between steric and 
electrostatic stabilization are listed below in Table 1.1. Briefly, steric stabilization is simple and 
requires the addition of a suitable polymer that is relatively insensitive to the presence of 
electrolyte dyes due to the steric hindrance of the polymer chain (Figure 1.6). In contrast and 
electrostatic-stabilized dispersion will be unstable and will coagulate. They are less effective in 
non-aqueous dispersion media than they are in aqueous media. This coagulation induced by an 
electrolyte is usually irreversible, while the flocculation of a sterically stabilized dispersion can 
be usually reversed. 




Figure 1.6: Illustration of the A) electrokinetic stabilization where charged ions adsorb on the surface of 







Table 1.1: A comparison of electrostatic and steric stabilization. 
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1.8.3 The biosynthesis route 
The idea of taking nanoparticle synthesis through a biosynthetic route requires the development 
of environmentally safe protocols. To ensure safety and efficacy, a minimum number of steps 
should be included using less toxic materials, and fewer reagents under appropriate laboratory 
conditions. This has led to widespread approaches for the synthesis of nanomaterials and the 
subsequent growth of advanced structures (Ahmad et al., 2009). Inorganic metal salt ions are 
generally toxic to microorganisms once in contact with these foreign species. The foreign ions 
inside the cell trigger a change of redox states. This fundamental characteristic of 
microorganisms is being applied in areas such as bioremediation, nanoparticle synthesis and 
microbial corrosion (Dameron et al., 1989). Studies show that eukaryotic and prokaryotic 
microorganisms produce nanoparticles within their cell walls. Gold and silver nanoparticles have 
been synthesized by reacting the metal salts with Verticullium, a family of fungi in the genus of 
Ascomycota, resulting in the intracellular deposition of nanoparticles. Klebsiella aerogenes 





Lactobacillus strains which are present in buttermilk have also been used for large scale 
production of Au and Ag when exposed simultaneously to the metal salts of both elements (Nair 
and Pradeep, 2002). 
1.9 Integration of organic molecules with nanoparticles 
Zhou et al., 1991; Gao et al., 1993 and Kupfer et al., 1994 have shown that several cationic 
polymers can form complexes with DNA and that linear and branched structures of poly L-lysine 
(PLL) and polyethyleneimine  (PEI) do not have a major effect on transfection efficiency. A 
complex can easily be formed between cationic polymers and DNA because of charge 
interaction. Amino acids hold the promise to be used in bio-functionalization of gold 
nanoparticles. Amino acids stabilize the AuNPs because their functional groups have a high 
affinity for gold. These groups are commonly known for their sulfhydryl groups (-SH) and amine 
groups (-NH2). One of the simplest representations of protein surfaces are gold nanoparticles 
capped with amino acids (You et al., 2005). Citrate-capped gold nanoparticles have been 
functionalized by ligands for improving stability. Mangeney and coworkers (2002) covalently 
derivatized a hydrophilic polymer monolayer bearing terminal disulfide groups. The resulting 
colloidal particles were found stable and ready for biological use. They successfully converted 
negatively charged citrate-capped gold nanoparticles into positively charged ones, by displacing 
the citrate and chloride on the particles by thioctic acid (TA), and then exchanged TA with thiols 
possessing the desired functionality. Brust and coworkers (1994) produced monolayer-protected 
gold nanoparticles of reduced dispersity and controlled size. The resulting compounds exhibited 
great stability when dispersed in organic solutions. This procedure was further explored and a 
wider range of monolayer-protected gold clusters (MPC’s) were synthesized. These MPCs 
capping layers containing the thiol ligands can be straight-chain alkanethiolates of different 
length, glutathione (Schaaf et al., 1998), tiopronin (Kohlmann et al., 2001 and Templeton et al., 
1999), thiolated polyetheylene glycol (Bartz et al., 1999), p-mercatophenol (Brust et al., 1995) 






1.10 Functionalization of gold nanoparticles with amino acid and cationic polyelectrolytes 
An ideal approach is to functionalize the surface of AuNPs with biocompatible ligands to yield 
gene delivery systems that simultaneously yield low toxicity and high gene transfer efficiency in 
living cells (Ahmed et al., 2009). The non-covalent approach is seen as ideal for the attachment 
of nucleic acids, as it prevents denaturation of the nucleic acids, and it also enhances the release 
of the nucleic acid from the AuNP complex into the cell (Ahmed et al., 2009).        
Poly-L-lysine (PLL) is a linear polymer of the amino acid lysine which is essential for human 
health (Kim et al., 2013). It has shown pronounced activity with DNA and cell membranes and is 
a positively charged amino acid polymer with approximately one HBr per lysine residue (Figure 
1.7). The hydrobromide allows the poly-L-lysine to be in a crystalline state so that it can be 
soluble in water. A small amount of product may be found in the beta conformation because the 
HBr interferes with hydrogen bonding between the amino and / or carboxyl groups, or with N or 
O containing moieties. PLL exhibits stimulatory activity towards production of immunoglobulin, 
and has found to increase the production of interferon-beta without influencing cell proliferation. 
It can assume different conformations such as random coil, α-helix and β-sheet of its secondary 
structure depending on temperature and pH. In general at neutral pH, PLL forms an extended 
random coil due to repulsions between protonated amine groups. The interaction between DNA 
and PLL were identified to be electrostatic when the lysine residues of PLL were positively 
charged and to be hydrogen bonding when the residues were deprotonated. AuNPs can be 
functionalized with PLL through covalent attachment via an amide group. PLL possesses many 
active amino groups which makes it useful in promoting cell adhesion (Zhang et al., 2006). As 
the functional group on the AuNP it provides advantages, such as good compatibility, abundance 
of active amino groups, a flexible molecular backbone and relatively good solubility in water 
(Zhang et al., 2006). Some free amino groups on the PLL molecular chains can cross link with 
the carboxyl group of AuNP, whilst the other residual free amino group can act as a relatively 
friendly and form a soft linker between the AuNP and bioactive molecules such as DNA (Zhang 



















































Figure 1.7: Common cationic polymers for functionalization of anionic AuNPs.  
The good biocompatibility and water solubility of PLL, coupled to the abundance of available 
active amino groups for DNA attachment, indicates that PLL functionalized AuNPs may be a 
potential viable option as future non-viral gene delivery systems (Zhang et al., 2006).                                     
Polyethylenimine (PEI) is a branched polymer that is used as a polyelectrolyte multilayer on 
charged surfaces to provide a biocompatible coating. There has been a flurry of interest in this 
polycation and its role as a gene carrier due to its “proton-sponge” effect in the endosomal 
compartment ensuing high transfection efficiency. It has hence a privileged place in the 
components of non-viral gene delivery. It is composed of ethyleneimine monomers with the 
tertiary amine of PEI acting as a reductant and stabilizer. The amine functional groups bind 
tightly to colloidal gold by virtue of the available electron lone pair. PEI in its branched form is 





with branch sites arising from specific interactions between two growing polymer molecules. 
The branched form of PEI has yielded significantly greater success in terms of cell transfection 
and is therefore the common form of PEI currently used in gene delivery. PEI is non-degradable 
and its molecular weight tends to correlate with its cytotoxicity and gene transfer activity. High 
molecular PEI >25 kDa exhibits a high transfection efficiency and high toxicity. In contrast PEI 
with low molecular weight <25 kDa is less toxic and cannot be used as a gene delivery vector 
because of its low transfection efficiency (Kim et al., 2013). Due to its abundant positive surface 
charges, PEI is able to condense the negatively charged DNA into complexes with a net positive 
charge. PEI/DNA complexes can act as ‘proton sponges’ after they cross the cellular membrane 
via the endocytic pathway (Kim et al., 2013). PEI has a backbone of 2 carbons followed by 1 
nitrogen atom and 3 amine groups each with the potential to be protonated. This gives PEI the 
attribute of serving as an effective buffer through a wide pH range. Coating of AuNPs with 
ligands having buffering capacity such as PEI provides effective release of the nucleic acid 
payload through the “proton sponge effect” (Niidome et al., 2008 and Thomas et al., 2003).  
 
Protonation of the ionisable amino groups of PEI leads to an influx of counter ions such as 
chloride, which in turn increases the endosomal osmotic pressure, causing rupture of the 
endosomal membrane and release of its contents (Figure 1.8). PEI raises the endolysosomal pH 
which alters protein folding within the endolysosome, and possibly inactivates degradative 
enzymes thereby inducing a water influx into the endosome causing the PEI/DNA complex to 
escape (Behr, 1997). To describe PEI’s proton ability, one needs to obtain its pKa. To obtain 
PEI’s pKa requires an ionization constant for every amino group (Godbey et al., 1999). 
Depending on the molecular weight of PEI being analysed the number of amine groups can 
easily exceed 1000. PEI-mediated gene delivery has the potential to transfect cells with large 
sizes of genetic material (Abdallah et al., 1995). One of the problems for in vivo gene delivery 
mediated by PEI and liposomes is that the transfection efficiency is inhibited by serum (Goldman 
et al., 1997). Studies have shown that PEI-mediated transfection decreased in the presence of 
10% serum (Erbacher et al., 1998). The deposition of oppositely charged alternate layers of 





the cytoplasm and the conjugates showed no cytotoxicity (Elbakry et al., 2009). They also 
demonstrated high stability and effective transfection in multiple myeloma cells (Crew et al., 








Figure 1.8: Diagram showing endosomal escape by the “proton-sponge effect”. The proton pumps eg. 
ATPase, pumps H+ ions into the lumen of the endosome. A parallel influx of Cl− ions and water 
accompanies the influx of protons to maintain electric neutrality. This swells and eventually ruptures the 
endosomal membrane allowing its contents to escape. Sourced from Fuller et al., 2008. 
 
Chitosan (Chit) is a natural carbohydrate polymer found in the exoskeleton of marine 
zooplankton. They are also used in dietary supplements, water treatment, food preservation and 
medicinal applications. A large increase in chitosan research has been carried out mostly due to 
its biocompatibility, biodegradability, non-toxicity and other unique properties. It has been 
investigated as a non-viral vector offering several advantages including high cationic potential. 
The properties of chitosan are dependent on its molecular weight and viscosity (Islam et al., 
2011). Chitosan is produced by the hydrolysis of the aminoacetyl groups of chitin from crabs or 
shrimps in aqueous alkaline solution. The functional groups allow simple coupling of 
extracellular and intracellular targeting ligands. It is one of the most reported non-viral naturally 
derived polymeric gene carriers with a strong affinity for DNA. It is insoluble in water but 
soluble in dilute aqueous acids such as acetic acid. Lower molecular weight chitosan (poly-D-
glucosamine), 5400 g/mol in its physical form, with a 75-85% degree of deacetylation was 
employed in this study.  
Chitosan with higher molecular weight seem to be more effective as food preservatives than 
those with lower molecule weight (Dutta et al., 2004). It is a flocculent, protein precipitating, 





used as a heavy metal trapper (Lee et al., 2002). Factors affecting transfection efficiency of 
chitosan/DNA complexes include the optimum pH of 6.8-7, charge ratio (optimum being 3-5) 
and optimum serum content (10-20 wt %). Degree of deacetylation and molecular weight has a 
major influence on its biological and physicochemical properties. Chain entanglement has been 
attributed to the formulation of chitosan with DNA (Kiang et al., 2004). High molecular weight 
chitosan entangle free DNA more easily once the initial electrostatic interaction has occurred. It 
is capable of protecting the condensed DNA from degradation by DNases and serum 
components. At acidic pH the primary amines become positively charged reflecting a pKa of 
around 6.3-6.4 (Li et al., 1996). Protonated amines of chitosan facilitate its binding to negatively 
charged DNA and condense into particles through phase separation. At pH 6.9 chitosan/DNA are 
positively charged and can bind with the negatively charged cells through electrostatic 
interaction (Kima et al., 2007).  
Cysteine (Cys) is commonly used as a coating agent that wraps AuNPs intended for biomedical 
application. Figure 1.9 depicts cysteine binding to citrate capped gold nanoparticles. Cysteine is 
a major biological source of sulphur and is one of the two common sulphur-containing amino 
acids with a thiol group (-SH) on the side chain. It is a neutral polar amino acid with limited 
hydrophilic properties with pKa values of 1.96, 8.18 and 10.28 respectively. The biosynthesis of 
cysteine occurs through the initial condensation of homocysteine and serine via cystathionine 
synthase to form cystathionine, which in turn undergoes cleavage by cystathionase to give 
cysteine and α-ketobutyrate. The addition of the cysteine solution to the colloidal gold leads to a 
colour change of bluish-black. This kind of colour change as an effect of aggregation, is a well 
understood phenomenon (Mayya et al., 1997). When the inter-particle distance in the aggregates 
decreases to less than average particle diameter, the electric dipole-dipole interaction coupling 
between the plasmons of neighbouring particles in the aggregates results in the bathochromic 
shift of the absorption band. This supports the observation and existence of covalent interaction 





    
Figure 1.9: Scheme of cysteine binding to citrate capped gold nanoparticles and bonds formation 
between particles. Adapted from Petean et al., 2008.  
 
L-lysine (Lys) is one of the three essential amino acids with basic side chains and is hydrophilic 
in nature. It contains an N-butyl amino group in its side chain which is protonated at 
physiological pH.  It is also one of the two purely ketogenic amino acids with a carboxyl group 
of pKa 2.2 and two amino groups with pKa’s of 9.0 and 10.2 respectively, which are 
significantly high. So a fully protonated lysine molecule has a +2 net charge. Direct interaction 
of lysine residues with the gold surface stabilizes the gold nanoparticle in solution. However at 
neutral pH, the complexation of lysine to gold is fairly weak (Joshi et al., 2004). 
1.11 Formation of cationic nanocomplexes with plasmid DNA 
There are three techniques commonly used to determine the size of the nanoparticles viz. 
Transmission electron microscopy (TEM), dynamic light scattering (DLS) and differential 
centrifugal sedimentation. Electron micrographs can be used to physically measure the size of 
the colloidal gold particles. Dynamic light scattering determines particle size by measuring the 
angles at which an incident light beam is scattered as a function of Brownian motion of the 
colloidal gold particle. Differential centrifugal sedimentation measures particle size by 





in a disc centrifuge. Both DLS and DCS methods use calibrated particle reference standards to 
estimate the size of the colloidal gold preparation. Colloidal AuNPs that are formed remain in 
suspension by their mutual electrostatic repulsion that is generated and maintained by a net 
negative charge on their surface. Cations present in the salt solution negate this charge repulsion 
and cause these “naked particles” to agglomerate and eventually precipitate out of solution. 
Binding of other stabilizing agents or proteins to the particles’ surface maintains the sol state by 
blocking the salt-induced precipitation of the colloidal gold particles. The binding of proteins to 
colloidal AuNP is dependent on the pH of the colloidal gold and the protein solution. DNA is 
susceptible to a variety of environmental challenges such as enzymatic, physical and chemical 
degradation during the transfection processes. If cleavage occurs in the gene-expressing 
sequence, fragmentation may result from strand breakage in the DNA which will lead to the 
reduction or elimination of gene expression. Therefore for recognition and delivery of DNA it is 
essential to cationically functionalize DNA. Cationic nanoparticles can bind to DNA which is a 
negatively charged molecule through a combination of electrostatic interactions, intercalation 
and groove binding. This binding induces changes in the DNA strand. If a nanoparticle has a 
high positive surface charge density, the DNA is likely to wrap and bend upon binding to the 
nanoparticle as in the case of chromatin. If the nanoparticle has a weak charge it will not induce 
dsDNA compaction (Railsback et al., 2012).  
1.12 Mechanisms of cellular uptake 
A gene/drug delivery carrier can affect the bio-distribution through passive or active targeting 
(Figure 1.10). With regard to passive targeting, this occurs as a result of the intrinsic 
physiochemical properties of the carrier. Size and charge are critical properties that need to be 
taken into account (Jeong et al., 2006). One approach in vivo involves the use of direct local 
delivery of the agents to the affected cell. It is an advantageous method since it protects the drug 
from the systemic circulation, but it is also very invasive since it involves surgical procedures 
and injections. The biggest challenge is the inability to accumulate large enough quantities of the 
nanocomplex on the tumor cells, resulting in low therapeutic efficacy (Ferrari, 2005). Active 





antibody-antigen. Active targeting improves the distribution of nanomedicine within the tumor 
interstitum (Drummond et al., 1991). The exact mechanism and pathways of how the body rids 
itself of the nanoparticle is still a subject of intense investigation. It is assumed that the liver is 
most likely the destination of spent nanoparticles, but they generally travel freely to other organs 













Figure 1.10: A representation of drug delivery via ‘active’ and ‘passive’ targeting, solid and dotted line 
respectively. Adapted from Ghosh et al., 2008b. 
The process of phagocytosis is usually involved in the uptake of particles larger than 500 nm. 
This was observed in macrophages, dendritic cells, monocytes and basophils. Most inorganic 
nanoparticles are synthesized to within the 1-100 nm range and are thought to be taken up by the 
cell via endocytosis. The size of these particles usually remains at less than 200 nm regardless of 
surface modification. Understanding the uptake of nanoparticles into cells is of crucial 
importance. Conjugates of gold nanoparticles with antibiotics provide promising results in the 





Zhang et al., 2006). Magnetic nanoparticles, liposomes and carbon nanotubes have been of great 
interest as non-viral carriers for gene delivery. As described previously, gold nanoparticles are 
attractive because of their unique properties. From early studies it was shown that gold 
nanoparticles functionalized with cationic quaternary ammonium groups can electrostatically 
bind to plasmid DNA, afford protection to the DNA from enzymatic degradation and could 
regulate DNA transcription of the T7 RNA polymerase (Boyer et al., 2010; Gao et al., 2006; 
Suzuki et al., 2008).  
1.13 Gold nanoparticles as potential transfection agents 
Functionalized AuNPs (FAuNPs) have demonstrated their use as delivery platforms for antisense 
oligonucleotides (ON) or small interfering RNA (siRNA) for targeted gene knockdown (Rosi et 
al., 2006 and Giljohann et al., 2009). The oligonucleotide:FAuNP complexes showed poor gene 
knockdown. However the siRNA: AuNPs complexes showed improved stability of the bound 
siRNA and were effective in transfecting cells and releasing the siRNA in a controlled manner. 
This method resulted in an extended gene knockdown when compared to lipofectamine mediated 
transfection of siRNAs (Giljohann et al., 2009). The initial indications regarding the cellular 
uptake mechanism of gold nanoparticle conjugates suggest that the particles enter cells via 
several routes as seen in Figure 1.11. When incubated with cells in vitro, the serum proteins such 
as albumin, fibrinogen and globulin that are present in the media interact with the AuNPs 
(Lacerda et al., 2010, Ghitescu et al., 1986 and Wang et al., 2010). Data describing 
thermodynamic parameters indicate that the interactions between gold nanoparticles and serum 
albumin are mainly hydrophobic in nature. It was further shown that when gold nanoparticles are 
incubated with cell culture media they become coated with serum proteins which favourably 
mediates the uptake of these gold nanoparticles by cells (Chithrani et al., 2006). The interaction 
of serum proteins with AuNPs is an interesting area of research that will have implications in 







1.14 Intracellular trafficking of nanoparticles 
Nanostructures in the extracellular space may be internalized via mechanisms and structures that 
include macropinocytosis, clathrin-coated pits, caveolae or via nonspecific uptake (Figure 1.11) 
(Conner and Schmid, 2003). These pathways initially traffic nanostructures into the cell and 
eventually to the early endosomes. Some nanostructures may be trafficked along regressive 
transport pathways ie. via the Golgi apparatus and endoplasmic reticulum, whilst others may be 
carried through from the late endosomes to lysosomes where they may be degraded 
(Dobrovolskaia and McNeil, 2007). The hypothesis that nanostructures escape into the 
cytoplasm from endosomes and lysosomes still needs validation and further study. Most 
nanoparticle preparations suffer from poor characterization of their size distribution. The 
physiochemical properties of nanoparticles strongly effect their cellular uptake. The nano-bio 
interface comprises many physiochemical interactions between nanoparticles and biological 
systems. The components that shape these interactions are still far from being completely 
studied. A major barrier for nanoparticles delivering any kind of cargo molecules into cells is 
their cellular uptake (Alkilany et al, 2009). For every delivery vehicle/particle an optimal size 
exists which accelerates cellular entry, membrane wrapping at the cell surface and intracellular 
passage. The uptake of gold nanoparticles into HeLa cells was investigated at sizes of 14, 30, 50, 
74 and 100 nm (Chithrani et al., 2006 and 2007) and revealed that the cellular uptake of gold 
nanoparticles coated with the ligand transferrin was observed to enter the cells via receptor 
mediated endocytosis.  
Factors contributing to low transfection ability may be related to the inefficient release from the 
endosomes into the cytoplasm. This can be seen by the differences in buffering capacities 
between PEI and chitosan due to its comparatively weak endo-lysosomolytic “proton sponge 
effect”. The escape of the polyplex from the endosome is an integral step for the release of the 
therapeutic drug or gene. Several endosomal disruptive agents have been suggested to overcome 
the endosomal barrier and to enhance transfection (Mao et al., 2010). These include fusogenic 
peptides, pH-sensitive neutral lipids and lysosomotropic chloroquine. Chloroquine, however may 





exist in a random coil conformation can undergo transition to an amphiphilic α-helical structure 
which facilitates penetration and leads to endosomal disruption. Furthermore, helper lipids such 
as dioleoylphosphatidylethanolamine (DOPE) commonly used in liposomal formulations, 
interact with the endosomal membrane and promotes fusion of the lipid/DNA complexes with 
the membrane thereby facilitating escape of DNA (Mao et al., 2001). 
 
Figure 1.11: Possible endocytosis pathways for cellular uptake of nanostructures. Nanostructures in the 
extracellular space may be internalized via mechanisms and structures that include macropinocytosis, 
clathrin coated pits, caveolae, or via nonspecific uptake. These pathways initially traffic nanostructures to 








Owing to its safety, non-viral gene therapy approaches are fast becoming popular compared to 
viral vectors in the scientific world. This study aims to design and synthesize gold nanoparticles 
(AuNPs) and to elucidate their biological effects on selected mammalian cells in culture. 
Furthermore these nanoparticles were functionalized with different polymers and complexed 
with plasmid DNA (pCMV-luc) in order to identify the safest and most efficient nanocomplex in 
vitro.  
1.16 Objectives  
 Gold nanoparticles will be synthesized and characterized 
 Morpho-isoform plasmid DNA pSG5 and pCMV-luc (circular, linear and nicked) will be 
purified 
 Functionalization and electrophoretic characterization of gold nanoparticles (FAuNPs) 
coated with amino-acids L-lysine and cationic polymers (CP); polyethylenemine (PEI), 
poly-L-lysine (PLL), chitosan (Chit) and cysteine (Cys) will be carried out 
 FAuNPs and CP will be incubated respectively with pDNA intended for gene delivery 
 Electrophoretic characterization, effect of the pH, concentration and ionic strength of the 
FAuNPs/pDNA and CP/pDNA will be assessed 
 DNA binding studies, cell culture, cytotoxicity and transfection studies will be 
investigated in four cell lines in vitro 
Novelty of work: The current study holds novelty in that the functionalized gold nanoparticles 
incorporates a range of different polymers and the effect of its interaction with four mammalian 
cell lines is observed.  
 
1.17 Outline of thesis 
Chapter 1 provides a review of the literature, background information, interest in the proposed 





the most widely used synthesis methods of gold nanoparticles and a description of the cellular 
mechanics involved in the uptake of these particles into the cell.  
Chapter 2 focuses on the experimental work that is involved namely the design and synthesis of 
the gold nanoparticles and their characterization. The preparation of the cationic polymers and 
functionalization of the AuNPs are discussed in detail. Characterization protocols using TEM, 
particle sizing, zeta potential, and electrokinetic studies are described. The methods used in DNA 
binding studies such as the band shift, nuclease protection and ethidium bromide intercalation 
assays are also discussed. Lastly the methodology for the in vitro studies in human embryonic 
kidney cells (HEK293), human cervical cancer (HeLa), human epithelial colorectal 
adenocarcinoma cells (Caco2) and human hepatocellular carcinoma cells (HepG2) are  outlined. 
Chapter 3 details the results obtained from all the experimental analyses followed by 
discussions and interpretations of the results.  
Chapter 4 concludes the research study and offers possible alternatives for future advancement 












Chapter Two  






Materials and Methods 
2.1 Materials 
2.1.1 Chemical reagents 
Gold (III) chloride trihydrate (HAuCl4.3H2O), 3-[4,5-dimethylthiazol-2-yl]-2.5-
siphenyltetrazolium bromide (MTT), tris (hydroxymethyl)-aminomethane (Mw 121.2 g/mol, Tris 
base), sodium dihydrogen phosphate (NaH2PO4) agarose, glycerol, dimethylsulfoxide (DMSO), 
phosphate buffered saline (PBS) tablets, ethidium bromide (EtBr, Mw 394.3 g/mol), sodium 
dodecyl sulphate (SDS, Mw 288.4g/mol), isopropanol, sodium borohydride (NaBH4), 2-[4-(2-
hydroxyethyl) piperazin-1-yl] ethanesulphonic acid (HEPES, C8H18N2O4S), sodium sulphate 
(Na2SO4), sodium chloride (NaCl), sodium bicarbonate (NaHCO3), sodium citrate trisbasic 
dehydrate (C6H5Na3O7.2H2O), EDTA disodium salt), xylene  cyanol and sodium dihydrogen 
phosphate (Mw 120 g/mol, NaH2PO4) were acquired from Merck, Darmstadt, Germany. 
Polyethylenimine branched (H (NHCH2CH2)n NH2, Mw 25,000 kDa), poly-L-lysine (Mw 1,000-
5,000), L-lysine (C6H14N2O2, Mw 149.19 g/mol), L-cysteinhydrochloride-monohydrat 
(C3H8ClNO2S.H20, Mw 175.64 g/mol), chitosan >75% deacetylated and bromophenol blue were 
purchased from Sigma-Aldrich Chemical Co. (St. Louis, USA). N, N, N’, N’-
ethylenediaminetetra acetic acid (Mw 372.2 g/mol, Ultrapure (18 Mohm) deionized water (Milli-
Q Academic, Millipore, France) was used in the preparation of all reagents. All other chemicals 
and reagents were of analytical grade or higher and purchased commercially.  
2.1.2 Plasmid DNA, cell lines and cell culture reagents  
Plasmid pCMV-luc DNA (6.2 kbp) was purchased from Plasmid Factory (Bielefeld, Germany). 
The plasmid was amplified in E.coli strain JM109 (Promega Corp.,Madison, USA) according to 
standard protocol. Plasmid pSG5 (4.1 kbp) was prepared at the San Cecilio Hospital, Granada 
Spain (Figure 2.1 A, B). Eagle’s Minimum Essential Medium (EMEM) with L-glutamine (4.5 
g/L), penicillin (10000 U/mL) streptomycin (10000 µg/mL) amphotericin B (25 µg/mL) mixture 





Fetal calf serum (FCS) was purchased from Hyclone GE Healthcare (Utah, USA). Reporter lysis 
buffer (5x) and luciferase assay reagent were purchased from Promega Corp. (Madison, USA). 
The Bicinchoninic acid (BCA) assay kit was obtained from Sigma-Aldrich Chemical Co. (St. 
Louis, USA). Human embryonic kidney cells (HEK293) was obtained from the Anti-viral Gene 
Therapy Unit, Medical School, University of the Witwatersrand, human cervical cancer (HeLa), 
human epithelial colorectal adenocarcinoma cells (Caco2) and human hepatocellular carcinoma 
cells (HepG2) were purchased from Highveld Biologicals (Pty) Ltd, Kelvin, SA. All tissue 
culture plastic ware, consumables and cryogenic storage vials were obtained from Corning 
Incorporated (New York, USA). All glassware used was cleaned and rinsed thoroughly with 
distilled H2O prior to use. 
2.2 Methods  
2.2.1 Synthesis of colloidal gold nanoparticles by citrate reduction  
Approximately 0.45 x 10-3 M of an aqueous colloidal gold solution was prepared by HAuCl4 
reduction with trisodium citrate according to the method of Turkevich et al., 1951. Figure 2.1 
shows the schematic representation of the citrate reduction of HAuCl4 followed by stabilization 
and functionalization via the ligand exchange reaction, leading to the formation of anionic gold 






Figure 2.1: The citrate reduction of HAuCl4 by the method of Turkevich, 1951.  
Briefly, a solution containing 0.11 mL gold colloidal in 25 mL water was boiled for 15 minutes 
in a 50 mL round bottomed flask. Thereafter 1 mL of 1% sodium citrate was added rapidly to the 
+ Au 










vortex of the solution. Upon addition of the citrate to the boiling tetrachloroaurate solution, the 
colour changed from pale yellow to dark blue within the first 3 minutes, gradually darkening 
over a period of about 5 minutes. After 15 minutes of reaction time the final colour of a deep 
wine red was obtained (Figure 2.3). This was boiled for a further 5 minutes on the heating 
mantle, removed, cooled to room temperature and thereafter stored in a dark bottle. The 













Figure 2.2: Flow chart for the synthesis of AuNPs. 
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Figure 2.3: The synthesis of gold nanoparticles by the method of Turkevich et al., 1951. 
2.2.2 Functionalization with amino acids and cationic polyelectrolytes 
A primary stock solution (100 mg/mL) of poly-L-lysine coated AuNPs were prepared, from 
which concentrations of 0.8, 1, 5, and 10 mg/mL were set up. The resulting Au-PLL 
nanoparticles were purified by centrifugation (Hettich Zentrifugen Mikro 220R) and filtered to 
remove the unbound PLL (Cebrian et al., 2011). For experimental purposes a stock solution of 
10 mg/mL Au-PEI was diluted to the desired concentrations of 1, 2, 5, 7 and 10 mg/mL and 
stored at room temperature. A chitosan stock (0.1 mg/mL) in H2O was diluted to 0.0125 µg/µL 
for experimental use. Due to poor solubility of chitosan, the solution was kept for 24 hours 
overnight under constant vortexing until a clear solution was obtained. Adsorption of L-cysteine 
onto Au was carried out by the modified method of Petean et al., 2008.  Briefly, 1 mL of the gold 
colloidal solution was added drop wise to 1 mL of the cysteine solution (20 mg/mL in water) 
under constant but moderate vortexing. This was washed three times with distilled water to 
remove any free polyelectrolytes that remained in solution. In the case of lysine, dilutions (0.01, 
0.1, 5, 10, 100, 200 mg/mL) were prepared from a stock solution of L-lysine (20 mg/mL) for 





2.2.3 Nanoparticle preparation and nanocomplex formation  
Nanoparticle suspensions were sonicated for 1 minute prior to use. The pCMV-luc DNA reporter 
gene (0.25 µg) was added to varied amounts of the cationic polymers (CP) and functionalised 
gold nanoparticles (FAuNP) respectively to produce a range of CP/FAuNP:pDNA (w/w) mass 
ratios. The mixtures were brought up to volume of 11 µL with sterile HBS (20 mM Hepes, 150 
mM NaCl ,pH 7.4), gently vortexed and incubated for 60 minutes at room temperature for 
complexation. The formation of the complexes with pDNA was confirmed using band shift 
assays (section 2.4.1). 
2.3 Particle imaging and analysis 
2.3.1 UV-vis optical spectrophotometry analysis  
The qualitative analysis of uniformity and stability of the gold nanoparticles were followed up by 
examining the absorption spectra of the individual nanoparticles and to correlate with literature 
that the expected surface plasmon resonance (SPR) absorption of the nanosized gold particles 
occurred at 534 nm. UV-vis absorption measurements were conducted and the spectra recorded 
by measuring dilute samples in a quartz cell with a path length of 1 cm (Malvern Instruments, 
Worcestershire, UK). Assuming no aggregation, these densities could then be used with the 
Beer-Lambert law to determine the concentration of gold nanoparticles. 
2.3.2 Imaging and size distribution analysis 
Particle size and morphology were determined using a transmission electron microscope Jeol (T 
1010) (Electron Microscopy Unit, UKZN and Applied Physics Department, University of 
Granada). One drop of the nanoparticle suspension was placed on a 400 mesh carbon coated 
copper grid (Ted Pella Inc. Redding, USA) which was covered by a carbon-supported film and 
allowed to air dry at room temperature before it was viewed at a magnification of 60 000x. The 
average diameter of particles was calculated by measuring 100-300 individual particles using the 
iTEM Soft Imaging Systems (SIS) MegaView III side-mounted 3 megapixel digital camera. The 
AuNPs were also viewed using the (NTA) NanoSight tracking analysis (Nanosight LM10, 





a metal surface and observed using the microscope. The zeta potential measurements were also 
performed in triplicate at pH 7. Briefly, one drop of the gold suspension coated by the respective 
amino acid and poly-electrolyte as described in section 2.2.3 above, was added to 10 mL of an 
aqueous solution of pH 3-9 and desired ionic strength. After 24 hours of incubation the pH was 
re-adjusted and the electrophoretic mobility was measured. Zeta potentials were calculated from 
the mean electrophoretic mobility by applying the Smoluchowski model based on the laser-
Doppler micro-electrophoresis technique. Citric acid and sodium hydroxide were used to adjust 
the pH.  
 
2.3.3 Photoluminescence spectra (PL) 
A drop of the required sample was placed into an empty cuvette and diluted with deionized 
water. The fluorescence spectrometer LS55 (FL WinLab, Perkin Elmer) was adjusted and the 
excitation set at 240 nm. Spectra were recorded by measuring dilute samples in a quartz cell with 
a path length of 1 cm. 
 
2.3.4 Ionic strength studies  
Ionic strength studies were performed to determine the compactness of the adsorbed layer. To 
achieve this we investigated the effect of electrolyte concentrations on the electrophoretic 
mobility (Ue).  Essentially in the presence of layers the mobility should tend towards zero 
because of the electric double layer compression at high ionic strength. The dispersion medium, 
sodium chloride, was prepared at different ionic salt concentrations of (1x10-4; 1x10-3; 2.5x10-3; 
5x10-3; 7.5x10-3; 1x10-2; 2.5x10-2; 5x10-2 mg/mL). 
2.3.5 Plasmid amplification 
Plasmid pCMV-luc DNA (Ampr) expresses the firefly luciferase (luc) reporter gene and is driven 
by the cytomegalovirus (CMV) promoter (Figure 2.4 A). The plasmid was amplified using E. 
coli strain JM109 according to a standard transformation protocol. The plasmid pSG5 (Ampr) is 
a eukaryotic expression vector constructed by combining pKCR2 and the Agilent pBS vector 
(Figure 2.4 B). Because of the high copy number of this plasmid, large quantities of double-





(luc) gene and the pSG5 vector is a pregnancy specific beta-1-glycoprotein 5 protein-coding 
gene. Both express the beta-lactamase for ampicillin resistance (Ampr). Agarose gel 
electrophoresis and UV spectroscopy were used to confirm the species and purity of the DNA. 
Concentration of the DNA was confirmed using a NanoDrop 2000c spectrophotometer (Thermo 
Scientific, Wilmington, USA). Stock concentrations of the DNA (0.25 µg/µL) were prepared 





























2.4 DNA binding studies 
2.4.1 Band shift assay 
The ability of the cationic nanoparticle and cationic polymers to bind plasmid DNA to form 
stable complexes was observed by the band shift or gel retardation assay. Agarose gels (1%) 
containing 1.5 µL ethidium bromide (10 mg/ ml) were prepared [(0.28 g agarose, 25.2 mL 
ultrapure deionized 18 Mohm water, 2.8 mL of 10 x electrophoresis buffer (0.36M Tris-HCl; 
0.3M Na2HPO4 and 0.1 M EDTA in 1 litre Mohm water, pH 7.5)] and poured into a sealed UV 
gel tray fitted with an 8 well comb and allowed to set for a minimum of 60 minutes. 
Nanocomplexes were prepared separately by incubating the reporter gene pCMV-luc DNA (0.25 
or 0.5 µg/µL) with increasing amounts of the respective CP or FAuNP at varying 
CP/FAuNP:pDNA weight ratios (w/w) for 60 minutes at room temperature (Table 2.1 and 2.2). 
All complexes were made up to a constant volume of 11 µL in HEPES buffered saline (HBS) in 
micro-centrifuge tubes. After the 60 minute incubation period, 3 µL of gel loading buffer 
(glycerol 50%, bromophenol blue 0.05% and xylene cyanol (0.05%) was added to the complexes 
and 11 µL of each sample was loaded into the wells and then  placed in a Mini-Sub® 
electrophoretic apparatus (BioRad Laboratories, Richmond, USA). Electrophoresis was 
performed at 50 V for 90 minutes in 1x electrophoresis buffer at room temperature. CP and 
FAuNP interaction with the pDNA was viewed and images captured at exposure times of 1-2 












Table 2.1: Varying amounts of the FAuNPs and pCMV-luc DNA used in the band shift assay. 
Components 
AuNP-PEI 
1:0 1:6 1:8 1:10 1:12 1:14 1:16 1:18 













DNA (0.25 µg/µL) 1 1 1 1 1 1 1 1 
HBS 10 9.25 9 8.75 8.5 8.25 8 7.75 
Components 
AuNP-PLL 
1:0 1:3.2 1:3.4 1:3.5 1:3.7 1:3.8 1:4 1:4.2 













DNA (0.25 µg/µL) 2 2 2 2 2 2 2 2 
HBS 9 7 6.9 6.8 6.7 6.6 6.5 6.4 
Components 
AuNP-Cys 
1:0 1:40 1:41 1:42 1:43 1:44 1:45 1:46 













DNA (0.25 µg/µL) 2 2 2 2 2 2 2 2 
HBS 9 8 7.98 7.95 7.93 7.9 7.88 7.85 
Components 
AuNP-Chitosan 
1:0 1:0.04 1:0.08 1:0.16 1:0.2 1:0.24 1:0.28 1:0.36 













DNA (0.25 µg/µL) 1 1 1 1 1 1 1 1 







Table 2.2: Varying amounts of the Cationic polymer and pCMV-luc DNA used in band shift assays. 
Components 
PEI 
1:0 1:4 1:6 1:8 1:10 1:12 1:14 1:16 






(2.5) - - - 
DNA (0.25 µg/µL) 1 1 1 1 1 - - - 
HBS 10 9.5 9.25 9 8.75 - - - 
Components 
PLL 
1:0 1:0.12 1:0.24 1:0.38 1:0.50 1:0.62 1:0.74 1:0.88 













DNA (0.25 µg/µL) 2 2 2 2 2 2 2 2 
HBS 9 8 7 6 5 4 3 2 
Components 
Cys 
1:0 1:33 1:34 1:35 1:36 1:37 1:38 1:39 













DNA (0.25 µg/µL) 2 2 2 2 2 2 2 2 
HBS 9 8.18 8.15 8.13 8.1 8.08 8.05 8.03 
Components 
Chitosan 
1:0 1:0.05 1:0.08 1:0.16 1:0.2 1:0.24 1:0.28 1:0.36 













DNA (0.25 µg/µL) 1 1 1 1 1 1 1 1 






2.4.2 Nuclease protection assay 
To confirm whether the cationic polymers on their own or the functionalized gold nanoparticles 
could provide adequate protection to the adsorbed plasmid DNA from nuclease degradation, 
foetal bovine serum (FBS)-mediated digestion was assessed using agarose gel electrophoresis. 
The PEI and Chitosan based complexes contained increasing amounts of nanoparticle 
concentrations and a constant amount of pCMV-luc DNA (0.25 µg/µL) while the PLL and 
Cysteine based complexes contained 0.5 µg/µL of pCMV-luc DNA, made up to a volume of  14 
µL in HBS (pH 7.4) at room temperature. Three ratios (sub-optimal, optimal, supra-optimal) 
were selected based on the band shift assay results as set out in Table 2.3 and 2.4. A positive 
control (C1) containing naked DNA with no FBS and negative control (C2) containing FBS 
treated DNA were set up. The complexes were incubated for 30 minutes and thereafter treated 
with FCS (excluding positive control) to a final concentration of 10% (1 µL) and incubated 
further at 37 °C for 4 hours in a temperature controlled water bath. Thereafter EDTA (1.1 µL, 
10mM) was introduced to stop the nuclease reaction. Approximately 0.5% SDS (1.33 µL, w/v) 
was then added to the complexes which were incubated for a further 20 minutes at 55°C to 
facilitate release of the DNA.  At the end of the incubation, gel loading buffer (3 µL) was added 

















1:8 1:10 1:12 1:3.2 1:3.4 1:3.5 















1:40 1:41 1:42 1:0.04 1:0.08 1:0.16 











HBS 8 7.98 7.95 8 7 6 
 




1:4 1:6 1:8 1:0.62 1:0.74 1:0.88 















1:36 1:37 1:38 1:0.05 1:0.08 1:0.16 


















2.4.3 Ethidium bromide intercalation assay 
The ethidium bromide intercalation assay was carried out to determine the level of pDNA 
condensation. Approximately 100 µL HBS was dispensed into a control and test well in a 96-
well FluorTrac flat-bottom black plate. To each well 2 µL ethidium bromide (100 µg/µL) was 
added. The fluorescence value at excitation and emission wavelengths of 520 nm and 600 nm 
respectively was then read in a GloMax®-Multi Detection System (Promega BioSystems, 
Sunnyvale, USA) to provide a baseline relative fluorescence of 0%. Thereafter, DNA (1.2 µg) 
was introduced to both wells and this fluorescence intensity reading was set at 100%. Cationic 
polymers (CP) and the functionalized Au nanoparticles (FAuNP) (1 µL aliquots) were added to 
the respective EtBr/pDNA solutions followed by a 30 second brisk vortex to promote uniformity 
in the solution prior to recording the respective fluorescence intensities. This was continued until 
a plateau in fluorescence readings was reached. All measurements were conducted in triplicate at 
25°C and the relative fluorescence (Fr) was plotted against CP or FAuNP mass ratios using the 
equation Fr (%) = (Fi – F0)/ (Fmax - F0) x 100 where F0 is the fluorescence intensity of un-
intercalated EtBr in the absence of pDNA, Fmax is the fluorescence intensity of fully intercalated 
EtBr in pDNA and in the absence of CP or FAuNP, and Fi is the fluorescence intensity for a 
given concentration of nanoparticle (Sun et al., 2009). 
2.5 In vitro cell culture and transfection studies 
2.5.1 Growth and maintenance of cell lines  
All media preparations and cell culture work were performed in an Airvolution Class II 
Biosafety cabinet. All surfaces were wiped with 70% ethanol and only sterile pipettes, disposable 
tubes, 25 cm2 flasks, multi-well plates and pipettes tips were used for cell culture studies. Cells 
were initially grown in 25 cm2 tissue culture flasks containing 5 mL of EMEM supplemented 
with 10% (v/v) gamma-irradiated FBS and antibiotics (100 U/mL penicillin, 100 µg/mL 
streptomycin) at 37 °C  in a HEPA Class 100 Steri-Cult CO2 incubator (Thermo-Electron 
Corporation, Waltham, Massachusetts, USA). Cell growth was monitored daily under a Nikon 
TMS (Nikon Corp., Tokyo, Japan) inverted microscope. Medium was changed approximately 





2.5.2 Reconstitution of frozen cells  
Frozen vials of cells were removed from the biofreezer (-80°C) and placed immediately in a 
water bath at 37 °C to thaw. Thereafter the cell suspension was transferred aseptically to a micro-
centrifuge tube (2 mL) and microfuged at 3000 rpm for 1 minute. The supernatant containing 
DMSO was thereafter decanted and the pellet resuspended in 1 mL of fresh pre-warmed 
medium. The reconstituted cell suspension was introduced to a flask containing 5 mL of growth 
medium. The flask was then placed in the incubator overnight at 37 °C under a humidified 
atmosphere and 5% CO2. The medium was replaced the following day to remove traces of 
DMSO which is toxic to cells above 4 °C. Cells were left to grow and maintained in culture until 
confluent and could be used or experimental purposes.  
2.5.3 Trypsinization  
Complete growth medium and trypsin were pre-warmed in a 37 °C water bath. Spent medium 
was decanted and cells were washed with 5 mL PBS (150 mM sodium chloride, 2.7 mM  
potassium chloride, 1 mM potassium dihydrogen phosphate, 6 mM disodium hydrogen 
phosphate, pH 7.5)  Trypsin-versene (1 mL) was added to cover the cells in the flask. The flask 
was allowed to stand for 1-5 minutes depending on the trypsinization time required for the cell 
line used. The process of trypsinization which is driven by the proteolytic enzyme trypsin, 
catalyses the cell dissociation and digests the proteins that allow the cells to adhere to the flask. 
Cells were viewed under the inverted microscope to observe rounding off during trypsinization. 
Dislodging of the cells from the flask was aided by gently tapping of the flask against the palm 
of the hand. The activity of trypsin was inhibited by the addition of 2 mL medium containing 
serum. Cells were split according to pre-determined ratios into 25 cm2 flasks or multi-well plates, 
or alternatively cryopreserved. Cell counting was facilitated using a Millipore ScepterTM 
handheld automated cell counter (Millipore Corporation, Billerica, MA, USA) prior to plating of 








After trypsinization of adherent cells, cells were pelleted by configuration at 3000 rpm for 1 
minute. The pelleted cells were re-suspended in 0.9 mL growth medium and 0.1 mL DMSO (10 
%) which is a cryoprotective storage medium. The suspension was vortexed and aliquoted into 
sterile 2 mL cryogenic storage vials. Cells were frozen at a rate of -1C per minute in a 
NalgeneTM “Mr Frosty” Cryo 1C freezing container containing isopropanol to a temperature of -
70°C. Cells were stored temporarily in a -80°C biofreezer (Nuaire, Lasec Laboratory and 
Scientific Equipment) or in liquid nitrogen for long term storage.   
2.5.5 In vitro MTT reduction assay 
Cells at or near confluency were trypsinized and seeded into clear 48-well plates at a seeding 
density of 2.4 - 2.9 x 104 cells/well. Cells were incubated at 37 C for 24 hours to allow for 
attachment. Thereafter the medium was replaced and the respective CP / FAuNP:pCMV-luc 
DNA complexes were added and cells allowed to incubate for 48 hours at 37 C in 5% CO2. 
Complexes were prepared as set out in Tables 2.5 and 2.6. A positive control was set up which 
contained only cells and no pDNA or complexes and assumed to have 100% cell survival. The 
assay was done in triplicate. After 48 hours the spent medium was removed and 200 µL fresh 
growth medium plus 200 µL MTT reagent (5 mg/mL in PBS) was added to each well. After a 4 
hour incubation at 37C the MTT infused growth medium was removed from each well and 
discarded. The insoluble formazan crystals were solublized by the addition of 200 µL DMSO 
and gently shaken. Absorption was read at 570 nm in a Mindray MR-96A microplate reader 














1:8 1:10 1:12 1:3.2 1:3.4 1:3.5 















1:40 1:41 1:42 1:0.04 1:0.08 1:0.16 
Sample (µL) (w/w) 1 (20.5 µg) 
1.02 









HBS 6 5.98 5.95 6 5 4 
 





1:4 1:6 1:8 1:0.62 1:0.74 1:0.88 















1:36 1:37 1:38 1:0.05 1:0.08 1:0.16 



















2.5.6 Transfection analysis  
After reaching confluency, cells were trypsinized and plated in 48-well plates as outlined in 
2.5.5. All nanocomplexes were freshly prepared as set out in Tables 2.5 and 2.6. The assay was 
conducted in triplicate. Two cell controls were set up, one unexposed to nanoparticles/cationic 
polymers or pDNA and one exposed to free naked pDNA in the absence of 
nanoparticles/cationic polymers (0.25 µg/µL per well). After 24 hours the nanocomplexes were 
added to the cells, and cells incubated for 48 hours at 37C in 5% CO2. Thereafter the cells were 
subjected to the luciferase assay (2.5.7). 
2.5.7 Luciferase Assay 
Cells were washed twice with 0.2 mL PBS and lysed with 80 µL reporter lysis buffer (1x) ( 25 
mM tris-phosphate, pH 7.8; 2 mM dithiothreitol, 2 mM 1,2-diaminocyclohexane – N, N, N’N’- 
tetra-acetic acid, 10% (v/v) glycerol, 1% (v/v) triton X-100). The plates were rocked gently on a 
STR 6 platform shaker (Stuart Scientific, Staffordshire, UK) for 15 minutes at 30 rpm. 
Thereafter the cells were gently scraped from the wells and the cell suspensions transferred to 1 
mL micro-centrifuge tubes and centrifuged in an Eppendorf 5418 centrifuge for 30 seconds at 
12000 x g. Approximately 20 µL of the cell free extracts were transferred to white 96 well plates, 
to which 50 µL of luciferase assay reagent (20 mM tricine, 1.1 mM magnesium carbonate 
hydroxide, pentahydrate, 2.7 mM magnesium sulphate, 0.1 mM EDTA, 33.3 mM dithiothreitol, 
270 µM coenzyme A , 470 µM luciferin, 530 µM ATP) was added just before bioluminescence 
was read. Prior to this the PMT detector (photomultiplier tube) on a GloMax®-Multi Detection 
System (Promega BioSystems, Sunnyvale, USA) operated by Instinct software was activated for 
5 minutes. The plates were gently shaken and relative light units (RLU) of all samples were 
immediately measured at room temperature. Light units were normalized against soluble protein 
content in the cell lysates, which was determined colorimetrically by the BCA protein assay at 
562 nm. Each data point was averaged over three replicates (n=3) and results were presented as 






2.5.8 Statistical analysis 
All data is presented as mean ± standard deviation (± SD n=3). Multi group comparisons of 
means were carried out using one-way analysis of variance (ANOVA) followed by Dunnett’s 
post hoc test for the MTT assay and the Tukey-Kramer post hoc test for the luciferase activity 
assay. Statistical significance for all tests was set at ***p<0.001 (high significance), **p<0.01 
(medium significance) and *p<0.05 (low significance). Each experimental value was compared 
to its corresponding control. Graphpad Instat Prism 4.0.3 software was used for statistical 














Chapter Three  























Results and Discussion 
3.1 Synthesis and characterization of gold nanoparticles 
The electrokinetic characterization of the AuNPs functionalized with PEI, PLL and L-lysine was 
carried out at the Applied Physics Department, University of Granada, Spain as part of the 
Erasmus Mundus (EMA2SA) Fellowship Award. The objective of the research was to study the 
role that size, concentration, type of morpho-isoform of the DNA molecule, pH and ionic 
strength play in determining the specificity and charge of the nanosensors for the analytes 
(Sections 3.1.-3.2). 
3.1.1 Nanoparticle tracking analysis  
The gold nanoparticles were synthesized and viewed using nanoparticle tracking analysis (NTA). 
This unique technique directly sizes and visualizes nanoscale particles in liquids with high-
resolution in real-time and with minimal sample preparation. The system provided count and 
concentration measurements by utilizing a laser light source to illuminate nanoscale particles that 
appeared individually as point scatters moving under Brownian motion. Below are images that 
show the distribution of the gold nanoparticles (Figure 3.1), confirming their strong light 












Size distribution of the non-functionalized gold nanoparticles averaged <100 nm. The total 
concentration was 36.65 particles/frame or 5.75 x 108 particles/mL. The laser light completed 
723 tracks at 23.75 frames per second (14240 frames with a drift velocity of 2491 nm/s) at a 
temperature of 25.5 °C. The plot seen below in Figure 3.2 is a 3-dimensional representation of 















Figure 3.2: Particle Size / Relative Intensity 3D plot of the gold nanoparticles. 
 
3.1.2 Photoluminescence spectra of Au  
The design and synthesis of fluorescent side-chain conjugated polymers which assemble 
supramolecularly, and are able to exhibit either chromogenic or fluoregenic responses due to 
non-covalent interactions, have gained considerable attention. Understanding the photo-physical 
processes are essential in order to improve the efficiency of our complexes. In order to 
understand the dynamics of the excited states of Au, photoluminescence (PL) was measured 
which is due to photo induced exciton states that undergo radiative recombination (Figure 3.3). 
The measurement of photoluminescence quenching gives a strong indication of the potential of a 





properties and quenching radius. Gold nanoparticles are highly attractive models for biological 
and fluorescent conjugated polymers. High performance fluorescence assay methods have been 
developed by taking advantage of this super-quenching ability of gold nanoparticles for optically 
sensing biologically important ions and molecules. The quenching of fluorophores that are 
attached to monolayer-protected gold nanoparticles and also the electron transfer from excited 
fluorophores to gold nanoparticles have been investigated (El-Sayed et al, 2010; McIntosh et al., 
2001). Direct binding between a fluorophore and a metal surface often results in the quenching 
of the fluorophores excited states. Energy transfer and electron transfer processes are considered 
to be the major deactivation pathway for excited fluorophores on a metal surface (Ipe et al., 
2002). The AuNPs were excited at 240 nm and emission was observed at 530 nm and 726 nm 


















Figure 3.3: Fluorescence quenching spectra of Au nanoparticles excited at 240 nm. The emission 



































3.1.2.1 TEM analysis of Au, Au-Lys and Au-Lys with pDNA respectively  
TEM micrographs revealed that the non-functionalized gold nanoparticles appeared spherical 
with smooth shapes and surfaces that were homogenous in the nanosized range of 25–50 nm 
with relatively monodisperse distributions (Figure 3.4). Subsequent observations showed no 
structural modifications such as aggregation or absorption changes for the particles after six 
months of storage at room temperature. The transition in colour of the AuNPs from pale yellow 
to ruby red confirmed the formation of citrate-capped gold nanoparticles (Turkevich et al., 
1951). When the pale yellow colour faded it signified the formation of the gold atoms which 
nucleated to form dark red nanowires (Lazarus et al., 2014). The citrate reduction route remains 
an attractive and reliable method of preparation, using a solvent such as water and no additional 
passivating ligand. The control over the nanoparticle size is related to the ratio of the agents used 
during preparation. The more reducing agents added, the smaller the nanoparticle produced. 
TEM micrographs of the L-lysine functionalised AuNPs and The Au-Lys NPs appeared as 

























                  
 
 
Figure 3.5: TEM of a) L-lysine bound to gold displaying aggregation b) Au-Lys/pDNA nanocomplex.             
 
3.1.3 UV–visible spectrophotometry 
The UV–vis absorption spectra in Figure 3.6 shows the absorbance peak of citrate-reduced 
colloidal Au nanoparticles. The surface plasmon resonance (SPR) absorption of the nanoparticles 
was observed presenting a well-defined absorption band with a maximum at wavelength λmax = 
534 nm. This value is characteristic and in agreement with the expected SPR absorption of the 
nanosized gold particles at this wavelength (Turkevich et al., 1951). The adsorption of L-lysine 
onto the surface of the gold particle was confirmed by a decrease in the absorbance peak to 519 
nm. A blue shift can be observed by the decrease in wavelength which also denotes an increase 
in particle size (Lazarus et al., 2014). Particle size and shape of the nanoparticles are of major 






Figure 3.6: UV-visible spectrophotometry of gold nanoparticles at absorbance 534 nm indicating a blue 
shift change to 519 nm confirming the adsorption of L-lysine. 
 
3.2 Gold nanoparticle and cationic polymer interaction 
3.2.1 Effect of pH and concentration of cationic functional groups  
Due to the anionic nature of the citrate reduced AuNPs it was of critical importance to 
functionalize the AuNPs with suitable cationic polymers (CPs) which will have a high affinity 
for the negatively charged cell membrane and enhance cell-mediated uptake processes (Wieber 
et al., 2012). The polymers chosen for this initial study were polyethyleneimine (PEI), poly-L-
lysine (PLL) and L-lysine. The chemistry of the functionalization of the AuNPs is of importance 
and the objective was to ensure that the bound molecule retained its biorecognition property such 
as light scattering and strong plasmon bands (Nikoobakht et al., 2003 and Jans et al., 2009). 
Surface functionalization of AuNPs is essential in order to target them to specific areas, organs 

























Aggregation of particles is a huge problem in most cases of biological systems. Normally 
colloidal AuNPs are stabilized by using long hydrocarbon ligand chains that contain various 
functional groups. For example mercaptocarboxylic acid is popular in the stabilization of AuNPs 
due to the strong affinity of sulphur for gold (Uson et al., 1978). It also has a photoluminescence 
property. There are several ways that have been employed to attach biological molecules to 
nanoparticles. The easiest method to functionalize and stabilize AuNPs is using electrostatic 
interactions. 
3.2.2 Electrophoretic mobility (Ue) of Au-Lys  
There are several theories that link electrophoretic mobility with zeta potential. L-lysine was 
initially chosen for its preference as an amino acid because it binds to the hydroxyl groups on 
citrate by its two amine groups. L-lysine exhibited positive electrophoretic mobility 
predominantly at pH 3 (Figure 3.8). This correlated to previous literature (Viota et al., 2012). 
Researchers investigated the adsorption of amino acids onto the surface of magnetite cores by 
measuring the electrophoretic mobility of the amino acid-coated magnetite particles and 
comparing the results with the ones obtained for the unmodified magnetite cores. Likewise in 
order to explain L-lysines’ particular pH dependence and its effect on Ue, we coated the gold 
nanoparticles with this amino acid and took into consideration the pKa of its ionized groups. L-
lysine has pKa values of 2.2; 8 and 10. At pH 3 the Au-lys NPs were protonated and L-lysine 
showed an overall +2 net charge. Therefore, there was attraction and adsorption between the L-
lysine and gold nanoparticles. The isoelectric point with minimum electrostatic repulsion, shifted 
4 units back (pH 3) from the norm (pH 7) after the gold was placed into contact with L-lysine. At 
pH 7, the Ue became negative because L-lysine bound to gold, forming cross bridges with each 
other resulting in aggregation (Figure 3.8). As the pH increased to 9, deprotonation followed 
owing to the negative Ue. The Au-Lys NPs experienced repulsion resulting in little or no 
adsorption. The difference in pH trend was further studied by modifying the surface adsorption 
of the AuNPs and varying the concentration of L-lysine in solution. As a result, at low L-lysine 





3.8 there was a distinct adsorption on the AuNP with the L-lysine coated particles, showing a 
significant negative mobility irrespective of pH.  
 
This again can be attributed to the fact that at high pH, L-lysine was deprotonated and any 
further increase in the concentration of L-lysine in solution led to saturation of the AuNP, 
resulting in cross-binding, aggregation and negative mobility (Figure 3.9A). The size distribution 
(Fig. 3.9 B) by intensity, correlated to the size by zeta sizing (Table 3.1). This was evident by the 
colour changes of the nanocomplex in solution (Figure 3.7A). It showed a distinct change from 
red to purple. It is likely that an increase in L-lysine concentration may have caused bridging 
leading to aggregation. At the lowest concentration of L-lysine (0.1-10 mg/mL) the colour was 
ruby red. Red is indicative of small particles of size 20–40 nm. After 24 hours the Au-Lys 
(Figure 3.7 B, C) turned purple indicating aggregation and instability. As the concentration of L-
lysine increased (100–500 mg/mL) the colour changed to a deeper purple which indicated the 










Figure 3.7: The instability of Au-Lys to bind to pDNA is confirmed by the image above. A) The increase 
in L-lysine concentration resulted in aggregation which shows bigger particles. This is indicated by the 

































                          



































Figure 3.9: A) Electrophoretic mobility (Ue) and B) Size distribution of Au-Lys as a function of L-lysine 














3.2.3 Electrophoretic mobility (Ue) of Au-PEI and Au-PLL 
PEI and PLL were investigated for their interaction and relationship with gold nanoparticles and 
to determine whether gold may reduce the toxicological effects of these cationic polymers. The 
AuNPs were combined with PEI and PLL to prepare (1, 2, 5, 7 and 10 mg/mL) of PEI-coated 
AuNPs and (1, 10 and 100 mg/mL) of PLL-coated AuNPs respectively. Au-PEI NPs displayed 
sizes in the range 70–120 nm (Figure 3.10 B) which was more acceptable to that of the Au-PLL 
NPs which was in the range 350–500 nm (Figure 3.10 A). Au-PEI nanoparticles were coupled to 
the three different isoforms of pDNA. The pDNA conjugates with the functionalised AuNPs 
(FAuNPs) were found to be positively charged with a considerable increase in particle size 
(Figure 3.10 A). The electrophoretic mobility of Au-PLL and Au-PEI as a function of its 
concentration in solution is shown in Figure 3.11. The results obtained show considerable 
increase in electrophoretic mobility of the cationic functionalized groups when adsorbed onto 
gold nanoparticles. The particle size of the complexes increased with increasing weight ratios, 
and the rise in positive electrophoretic mobility was due to the cationic character of both 
polymers.  
 
This result shows that PEI can condense pDNA into nanosized particles that are appropriate for 
gene delivery. A positive charge of the nanocomplex is necessary for the binding of the 
negatively charged phospholipids in the cellular membrane which will lead to efficient 
intracellular trafficking. Zeta potentials of the Au-PEI and Au-PLL NPs rapidly increased and 
reached a plateau above 1 mV, at weight ratios between 1 and 10 mg/mL. In the case of both 
CPs, the higher the concentration of the polymer the greater the positive charge (Figure 3.11). It 
is important to note that at the various concentrations of the PEI, the gold nanoparticles were 
already close to the saturation region as predicted in the law of Lambert Beer (Figure 3.11 B). It 
was not necessary to prepare the Au-PLL and Au-PEI nanoparticles at varying pH’s as they were 








Figure 3.10: Zeta sizing by dynamic light scattering of A) Au-PLL and B) Au-PEI as a function of its 































































Figure 3.11: Electrophoretic mobility Ue of A) Au-PLL and B) Au-PEI as a function of its concentration 
in solution. Error bars represents the mean ± SD, n=3. 
 











































3.2.4 Au-PLL interaction with pSG5 DNA 
Nanoparticle binding can facilitate DNA compaction in addition to partial strand separation 
(Ghosh et al., 2008a). We did not incubate the Au-Lys NPs with DNA because L-lysine was 
positive only at pH 3, which is too acidic for the proper physiological functioning of the body. 
Furthermore, the pH of blood is 7.4 and in order for the nanocomplexes to enter the cell and 
circulate in the body it has to be neutral or slightly positively charged. This study of Au-
PEI/DNA interaction was not continued due to the early literature citing toxicity to cells in vitro 
(Lee, 2007). However, Au-PEI revealed size distributions within the desired size range and 
positive electrophoretic mobility, and was only employed further with DNA plasmids in later 
studies, where its cytotoxicity and biological activities were assessed. Hence studies with Au-
PLL were conducted where Au-PLL was incubated with DNA pSG5. It exhibited size 
distributions in the range of 110–290 nm (Figure 3.13 B). As the concentration of PLL increased, 
the DNA strands wrapped tighter around the Au-PLL complex compacting it as seen in the TEM 
images (Figure 3.18 D), with a size decrease of more than 50% (Figure 3.13 B). An illustration is 
shown below in Figure 3.12 of the functionalization of AuNPs with CP and pDNA. Given that 
the smallest particle size was at 10 mg/mL, the Au-PLL NPs was prepared accordingly and 
incubated with DNA pSG5 of different isoforms as a function of their concentration. Results 
obtained (Figure 3.13 A) indicated that the Ue of linear and supercoiled isoforms tended towards 
zero. When supercoiled DNA was complexed to PLL it yielded a much lower effective charge 
than linear DNA, since the polyelectrolyte was compacted with a large amount of counter ions. 
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Figure 3.13: Ue of A) Au-PLL and DNA pSG5 as a function of DNA concentration and B) Size 
distribution of Au-PLL and DNA pSG5 as a function of PLL concentration. Error bars represents the 
mean ± SD, n=3. 
3.2.5 Effect of ionic strength                 
The ionic strength of the Au-PEI complex was investigated, with and without pDNA, to 





electrolyte concentrations on the Ue. Theoretically, in the presence of layers the mobility should 
tend towards zero because of the electric double layer compression at high ionic strength. The 
dispersion medium, sodium citrate, was prepared at different ionic salt concentrations of (1x10-4; 
1x10-3; 2.5x10-3; 5x10-3; 7.5x10-3; 1x10-2; 2.5x10-2; 5x10-2 mg/mL). The result in Figure 3.14 
showed that at higher salt concentrations, the mobility of the nanocomplexes approached zero 
which indicated that the overall charge was neutral. This suggested, that during transfection 
studies the complex should easily pass through the cell membrane. The results also revealed that 
at high ionic strength, electroneutrality was achieved and can be interpreted that the electric 
double layer was compact and stable. When the surface of the gold core was covered by PLL-
DNA and PEI-DNA (Figure 3.14), the particles did not display soft electrokinetic behaviour. The 
formalization derived by Sennato et al. (2004) which is in turn based on the complexation theory 
developed by Nguyen and Shklovskii (2001a and 2001b), describes the complexation of long 
polyelectrolytes with oppositely charged spherical bodies to a single negative molecule of DNA. 
The theory predicts that in a system, equilibrium is reached by the DNA concentration with 
lipoplexes. The same can be said for metal nanoparticles which allows us to predict the 








Figure 3.14: Ue of Au-PLL and Au-PEI and its interaction with supercoiled DNA as a function of ionic 






3.3 Nanocomplex binding and stability 
The size of nanoparticles determine their cellular uptake, endocytosis, cytotoxicity, bio-
distribution, and clearance pathway (Chithrani et al., 2006; Hirn et al., 2011; Pan et al., 2007; 
Semmler-Behnke et al., 2008; Sonavane et al., 2008). Citrate-stabilized AuNPs were not 
appropriate for biological purposes due to their lack of stability in the presence of salt. Hence, 
cationic polymers were employed as capping agents to enhance biocompatibility to cells. 
3.3.1 Sizing by dynamic light scattering and zeta potential analysis 
Nanoparticles with cationic surfaces have a high cellular uptake, low toxicity, and renal 
clearance rate compared to those with an anionic surface. A positive surface charge can support 
electrostatic interactions and attachment to anionic cell membranes, as cells are known to take up 
positively charged nanocomplexes more efficiently. An acceptable size for circulation of AuNPs 
is 45 nm (Wang et al., 2010). Small nanoparticles also show greater transfection efficiency 
(Zhang et al., 1999). TEM images showed that the nanoparticles were spherical and 
monodispersed in many cases with an average size of 76 nm. Mean particle size distribution and 
zeta potential of the nanoparticles and corresponding nanocomplexes are summarized in Table 
3.1. Dynamic light scattering characterization revealed the nanosized nanoparticles and 
nanocomplexes are accompanied by narrow SD (in brackets) as follows: Au-PEI 76 nm (0.269), 
Au-PEI/pDNA 217 nm (0.509); Au-PLL 207 nm (0.475), Au-PLL/pDNA 130 nm (0.217); Au-
Cys 9.6 nm (0.012), Au-Cys/pDNA 15.7 nm (0.098) and Au-Chit 29.8 nm (0.391), Au-
Chit/pDNA 186 nm (0.261). From these results there appears to be a correlation between 
nanocomplex size and zeta potential. The size increase of the non-functionalized AuNPs (25 nm) 
validated the success of polymer adsorption and functionalization (Table 3.1). Of particular 
interest is the size increase when the CP was adsorbed onto the AuNP. When the AuNPs were 
functionalized with PEI there was an increase in zeta potential and an increase in size. PEI has 
many residues with positive moieties, therefore the higher the PEI concentration the higher the 
surface charge of the nanocomplex. As noted in the Au-Lys, Au-Cys and Au-Chit samples, zeta 
potential decreases as the size of the nanocomplex increases. The AuNPs displayed an increase 





3.15). In addition this size decrease was confirmed by the ability of PLL to create a condensed 





  Table 3.1: Surface characteristics of the different AuNPs functionalized with cationic polymers and complexed to pCMV-luc DNA.                    




(µg/µL) Gel Retardation DNA:NP (w/w) 
Optimum Binding 




(nm) ± SD 
 
Zeta Potential  
(mV) ± SD Au NP pDNA 
Au 1 0 0 ND ND 25 ± 0.733 -17.0 ± 12.48 
Au-Lys 1 1 0 ND ND 77.6 ± 0.334 -46.5 ± 6.764 
Au-Lys/pDNA 1 1 0.25 ND ND 200 ± 0.429 -24.5 ± 6.764 
        
Au-PEI 1 2 0 ND ND 76 ± 0.269 42.4 ± 5.390 
PEI/pDNA 0 2 0.25 1:4 (0.25:1) 0.25:6 182 ± 1.210   46.2 ±2.123 
Au-PEI/pDNA 1 2 0.25 1:10 (0.25:2.5) 0.25:22 217 ± 0.509 53.8 ± 9.541 
        
Au-PLL 1 10 0 ND ND 207 ± 0.475 39.2 ± 4.565 
PLL/pDNA 0 10 0.5 1:0.88 (0.5:0.44) 0.5:48 195 ± 0.987 21.6 ± 2.315 
Au-PLL/pDNA 1 10 0.5 1:3.4 (0.5:1.60) 0.5:46 130 ± 0.217 47.9 ± 5.142 
        
Au-Cys 1 20 0 ND ND 9.6 ± 0.012 21.4 ± 0.019 
Cys/pDNA 0 20 0.5 1:37 (0.5:18.5) 0.5:320 11.9 ± 0.875 18.9 ± 0.256 
Au-Cys/pDNA 1 20 0.5 1:40 (0.5:20) 0.5:140 15.7 ± 0.098 16.4 ± 0.496 
        
Au-Chit 1 0.0125 0 ND ND 29.8 ± 0.391 32.5 ± 8.142 
Chit/pDNA 0 0.0125 0.25 1:0.05 (0.25:0.01) 0.25:0.25 94 ± 0.569 43.9 ± 4.156 




3.3.2 TEM of FAuNPs and nanocomplexes  
Surface modification is important for the endocytosis of AuNPs, since AuNPs without ligands cannot 
efficiently interact with nucleic acids and with the cell surface. Small gold nanoparticles approach 
the size of typical protein ligands and may inadvertently activate cell surface receptors. When 
endocytosis of AuNPs occurs, the AuNPs become wrapped within the vesicles. From previous 
studies (Wang et al., 2010), the optimal size of AuNPs required for efficient uptake by cells was 
around 45 nm, suggesting that this size could probably have the highest efficiency for drug delivery. 
On the other hand, large AuNPs which remain bound to the cell membrane can be used to reconstruct 
the morphology of the cell. 
 
TEM images of Au-PEI and Au-PLL appeared as oval, individualized shaped particles (Figure 3.15 
A, C). Upon addition of pDNA, the nanoparticles assumed a gel-like structure which can be 
identified as the nanocomplex. The particles sizes were altered due to the interaction of pDNA as 
seen in Table 3.1. Of striking interest is the Au-Cys TEM (Figure 3.16 A). Au-Cys revealed chain-
like structures that are known to be characteristic upon its addition to the citrate-stabilized gold 
aqueous dispersion. The citrate molecules are replaced by cysteine, resulting in the formation of an 
organic double layer (Majzika et al., 2010). The addition of cysteine to the gold colloidal mixture led 
to a blue to black colour change. This colour change is generally regarded as a sign of aggregation 
(Mayya et al., 1997 and Petean et al., 2008). Gold nanoparticles are particularly notorious for 
binding thiol ligands because of the high electronegativity of gold and electro-positivity of sulphur. 
Thus gold will preferentially bind sulphur containing compounds like cysteine. The formation of a 
covalent bond Au-S is due to the interaction of the positively charged amino group in cysteine 
(NH3+) and the negative charge on the surface of the gold nanoparticles bound by their –SH groups. 
This phenomenon could be explained through the zwitterion-type electrostatic interaction where 
assemblies are formed and is in agreement with reported data on the adsorption of cysteine onto 
AuNP (Petean et al., 2008). Also characteristic for cysteine mediated assembly of gold nanoparticles 
is the linear arrangement. This is seen in the TEM (Figure 3.16 B). Au-Chit appeared as round 






     Figure 3.15: Transmission electron micrographs of FAuNPs: A) Au-PEI, B) Au-PEI/pDNA C) Au- 







































         Figure 3.16: Transmission electron micrographs of: A) Au-Cys B) Au-Cys/pDNA C) Au-Chit D)  



















3.3.3 Band shift assays  
 
Before proceeding with further biochemical assays it was of major importance to determine the 
minimum amount of FAuNP and CP that was needed to efficiently bind and compact a specific 
amount of the pCMV-luc plasmid DNA. The electrostatic binding ability of the gold based cationic 
nanoparticles to incorporate the negatively charged pDNA was investigated using the band shift 
assay, which is also commonly referred to as the agarose gel retardation assay. Electrostatic 
interactions between the negatively charged nucleic acids, cationic polymers and functionalized gold 
nanoparticles respectively induced formation of CP/pDNA and FAuNP/pDNA complexes as 
investigated by the agarose gel retardation assay. The control lane (lane 1) contained a fixed amount 
of either 0.25 µg or 0.5 µg uncomplexed pCMV-luc DNA. It produced three conformations namely 
circular, linear and supercoiled. The FAuNP and CP were able to completely retard pDNA mobility 
as summarized in Table 3.1, at specific nanocomplex ratios. This assay is based on the premise that 
pDNA which is completely bound to the nanoparticle will not migrate into the agarose gel matrix 
because the negative charges on the pDNA are completely neutralized by the positive charges on the 
nanoparticle. On the other hand, pDNA that was not completely complexed by the cationic 
nanoparticle easily migrated towards the anode. At the ratios stated in Table 3.1, there was complete 
pDNA compaction making it impossible for further migration to take place at higher ratios. The 
binding affinities of the polymers to the gold nanoparticle is dependent on the different chemical and 
surface properties of the different polymers. 
The endpoint for each complex is indicated by an arrow. Lane 0 contained naked pDNA and lane 1-7 
contained the respective CP/pDNA or FAuNP/pDNA at different weight ratios, as outlined in Table 
2.1. At the optimal binding weight ratios as indicated by the arrows, the nanoparticles had 
completely condensed the pDNA forming an electroneutral complex. The point of electroneutrality 
or optimum binding weight ratios of the pCMV-luc DNA and FAuNPs (w/w) were: pDNA/Au-PEI 
(1:10), pDNA/Au-PLL (1:3.4), pDNA/Au-Cys (1:40) and pDNA/Au-Chit (1:0.08) and for the bare 
CP it was pDNA/PEI (1:4), pDNA/PLL (1:0.88), pDNA/Cys (1:37) and pDNA/Chit (1:0.05). The 
pDNA compaction by the FAuNPs had a strong influence on electrophoretic mobility within the gel. 
Due to the increased positive charges available on the CP, they were able to completely bind pDNA 
at lower weight ratios. As shown in Figure 3.17 A) PEI/pDNA was completely retarded and showed 
100% binding at the lowest weight of 1 µg (lane 1). Hence, at the higher weight ratios there was no 
more DNA to bind the excess CPs, and hence the complex is retained in the well as evidenced by the 
fluorescence observed on the gel (Figure 3.17 B, lane 3), showing 100% retardation of Au-PEI at 2.5 




dilutions were prepared to investigate binding at lower weight ratios, with no success as the 
complexes did not display any retarding ability. This could also be due to a decrease in the overall 
available charge of the nanoparticle thus preventing the nanoparticle from binding to the pDNA. 
Previous studies by McIntosh et al., 2001 demonstrated that quaternary ammonium-functionalized 
gold colloids can recognize DNA strands. It is also expected that nanoparticles containing primary 
ammonium groups, pK10, on the surface could bind to DNA (anionic) via ion-pairing at 
physiological pH of 7.4. 

























                     
 
             
Figure 3.17: Band Shift Assays of nanocomplexes. pCMV-luc DNA was kept constant in lane 0 with A, B, C, 
D = 0.25µg and E, F, G, H = 0.5µg. Lanes 1-7 contained the respective nanocomplex using the mass (µg) as 
follows. The endpoint is indicated in red: A) PEI: (1, 1.5, 2, 2.5) B) Au-PEI: (1.5, 2, 2.5, 3, 3.5, 4, 4.5) C) 
Chitosan (0.01, 0.02, 0.04, 0.05, 0.06, 0.07, 0.09) D) Au-Chit (0.01, 0.02, 0.04, 0.05, 0.06, 0.07, 0.09) E) PLL 
(0.06, 0.12, 0.19, 0.25, 0.31, 0.37, 0.44) F) Au-PLL (1.60, 1.68, 1.76, 1.84, 1.92, 2, 2.08) G) Cysteine (16.5, 
17, 17.5, 18, 18.5, 19, 19.5) H) Au-Cysteine (20, 20.5, 21, 21.5, 22, 22.5, 23).         
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3.3.4 Nuclease protection assay 
The ultimate goal of gene therapy will be its clinical application. However, when the nanocomplexes 
are administered in vivo, the serum components in the biological fluid can influence the constitution 
of the complex, often leading to their degradation. Hence, it is compulsory that all investigations are 
carried out in the presence of serum to attain conclusive correlations between in vitro and in vivo 
efficiencies. A good nanovector should bind and protect its DNA cargo from degradation by serum 
nucleases. Previous research based on liposomal transfection efficiency (Simberg et al., 2003), state 
that serum proteins have a rich protein layer called a protein corona which associates with the surface 
of lipoplexes when they come into contact with serum. This could also apply to the interaction of our 
cationic polymers studied, and it is highly possible that the same behaviour is being mimicked. The 
polymers namely PEI, PLL, cysteine and chitosan generally resemble components that the serum 
proteins would recognize and attack. This can destabilize the nanocomplex structure thus exposing 
the pDNA to degradation as seen in Figure 3.18.  
We evaluated the stability of the FAuNPs and CP/DNA complexes in the presence of serum using 
the nuclease protection assay. This assay showed the ability of the respective CPs and FAuNPs to 
protect their DNA cargo from digestion by the serum nucleases which would be encountered in an in 
vivo system. Often nanoparticles aggregate in saline and serum free medium because of the salt 
content in these solutions. The addition of serum can to some extent improve stability of these 
nanoparticles in the biological fluid by forming a protein halo or corona. Serum protein binding, 
however may alter the biological activity of some nanoparticles in more ways than just aggregation. 
Lacerda and colleagues showed that the binding kinetics between AuNPs and serum proteins is 
strictly size dependent. The bigger the particles, the higher the tendency to bind proteins (Lacerda et 
al., 2010). In this respect, it was our goal to develop an efficient non-toxic, non-viral vector that is 
safe and has favourable characteristics for gene delivery. Gold nanocomplexes were prepared with 
varying amounts of cysteine, poly-L-lyine, polyethylenemine and chitosan respectively and 
complexed with 0.25 µg of pCMV-luc. DNA is negatively charged and therefore requires specific 
masses of the nanoparticle to bring the entire nanocomplex to achieve electroneutrality. This was 
achieved by the gold nanoparticles serving as a scaffold for the DNA constructs.  
The two controls utilised in this assay were control 1 (C1) that contained untreated naked pCMV-luc 
DNA and control 2 (C2) that contained naked pCMV-luc DNA treated with 10% foetal bovine serum 
(FBS). The aim of these controls was to monitor the extent of serum nuclease degradation in 




from the nanocomplex after the incubation with serum. The DNA exposed to serum (C2) was fully 
digested as seen in lane 2 of all gels (Figure 3.18). Degradation of DNA to different extents can be 
seen in all the gels. The CP on their own were unable to fully sustain the protection of the bound 
pDNA, as no distinct DNA bands were visible on the gels. The FAuNP/pDNA gel patterns also show 
degradation and limited protection of the DNA. Au-PEI offered the highest degree of protection 
(Figure 3.18 B) as seen by the distinct intense fluorescent bands. Based on earlier results (Figure 
3.13 A), it was expected that bands of the circular and linear forms will be detected in the gel due to 
the interaction of FAuNP with the different isoforms showing that gold had the potential to 
electroneutralize the nanocomplex making it suitable for gene delivery.  
However, from the digestion assay, the Au-PEI was unable to fully protect the circular form here as 
it disappeared, and only the bands of the linear and super-coiled forms were predominantly visible. 
This could be partly due to the nicking of the circular form and possibly the supercoiled forms to that 
of a linear form by the nuclease enzyme. It is also possible that the proteins in the serum created a 
shield around the gold nanoparticles that “masked” its protection ability. In spite of the gold based 
cationic polymer binding strongly to the pDNA, it does not seem to provide the DNA with sufficient 
protection. In comparison to the plain CP where the DNA from the CP/DNA complexes were 
completely degraded by the serum nucleases, FAuNPs do provide partial protection to the DNA. 
Once again, when considering the degradation of the DNA, one has to take into account the DNA 
bending and strand separation possibility which exposed the pDNA. However, if successful 
transfection was eventually attained (section 3.4.3), then it is possible that the pDNA could not have 
been totally degraded and was able to enter the cell and the nucleus to effect transcription.  This 
could also be due to a phenomenon of the gold’s biophysical properties in the presence of serum that 
makes it difficult to view under the UV-light. Gold has been known to quench fluorophores and the 
serum proteins may have possibly clouded the light scattering ability of the gold. Furthermore, the 
AuNPs do not aggregate even under extreme pH in different ionic conditions or in the presence of 
proteins (Kanaras et al., 2002).  
Basically it can be assumed that the functionalized gold based nanoparticles were able to afford some 
protection to the pDNA compared to the cationic polymers on their own. The extent of the 
compaction of the pDNA by the nanoparticles which was investigated by the ethidium bromide 
intercalation assay (section 3.3.5) provides further evidence as to why some or most of the pDNA 
was degraded. From the results of these studies, it is clear that further studies and optimization of the 
FAuNPs are needed to ensure complete serum stability. One such optimization could be the addition 




serum and ensures their increased circulation times with view to in vivo gene delivery. PEG is often 
used as a ligand because of its colloidal stability which is assumed to be provided by a PEG brush 


























Figure 3.18: FCS-mediated digestion of FAuNPs. pDNA was kept constant in lane C1-C2 at 0.5 µg. Control 
1 (C1) contained naked pCMV-luc and Control (C2) contained FCS-treated naked pCMV-luc. The respective 
nanocomplex using the mass (µg) is as follows: A) Au-Cys (20, 20.5, 21) and Au-Chit (0.01, 0.02, 0.04), B) 
Au-PEI (2, 2.5,) and Au-PLL (1.6, 1.68, 1.76) and the CP C) PEI (1, 1.5), PLL (0.37, 0.44), Chit (0.02) and 
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3.3.5 Ethidium bromide intercalation assay 
The EtBr intercalation assay investigated the binding efficiency of the CP and FAuNPs to pDNA. 
EtBr is an aromatic fluorophore whose emission intensity is approximately 10 fold higher when 
intercalated between base pairs compared to its fluorescence in water or buffer (Lakowicz, 1999). 
EtBr binds between the adjacent base pairs of dsDNA by a process termed intercalation. The pDNA 
then dynamically opens a space between its base pairs by unwinding its helix. This unwinding causes 
changes to the pDNA such as lengthening, twisting and elongating of the base pairs. EtBr dispels any 
water molecules as water is a highly effective quencher. This causes EtBr to fluoresce. A decrease in 
fluorescence indicates displacement of the EtBr and binding of the pDNA by the CP or FAuNP 
respectively, which would prohibit EtBr intercalation. As the amount of CP and FAuNP increases, 
greater amounts of EtBr are displaced from the DNA causing a gradual or in some cases a rapid 
decrease in fluorescence emission. Ratios in Table 3.1 reflect the points of inflection at which 
FAuNP and its corresponding CP maximally displayed the EtBr.  
Results revealed that all the samples have compaction abilities because they successfully displaced 
EtBr and bound to pDNA at varying degrees. Samples were added in increments of 1 µg to the 
EtBr/pDNA until fluorescence readings reached a plateau. At this point maximum pDNA 
condensation had been reached. A trend was observed where the gold functionalized particles 
produced greater levels of fluorescence decay compared to its cationic polymer counterparts. In the 
case of the PEI, chitosan and the cysteine graph (Figure 3.19 A, B, D) a possible observation is that 
the cationic nature of the polymers saturated the pDNA thus inhibiting any further action by the 
cationic EtBr. On the other hand, with regards to the compacting nature of the pDNA by the 
FAuNPS, an interesting phenomenon that may have taken place is DNA strand bending. Railsback et 
al., 2012 investigated DNA interactions with functionalized AuNP and showed how binding events 
with these particles affect the structure of dsDNA. Nanoparticle binding can facilitate DNA 
compaction in addition to partial strand separation. It is of paramount importance to consider parts of 
strand unzipping due to strong interactions with the cationic ligands on the FAuNPs. The charge of a 
nanoparticle plays a crucial role in its ability to induce structural DNA changes. If a nanoparticle has 
a highly positive surface charge density the DNA is likely to wrap and bend upon binding to the 
nanoparticle as in the case of chromatin. Contrary to this finding if a nanoparticle is weakly charged 
it will not induce dsDNA compaction (Ke et al., 2007 and Torres and Baigl, 2011). This observation 
of compaction was confirmed in our band shift assay. Maximum percentage fluorescence decay for 
each FAuNP was: Au-PEI (79.3%), Au-PLL (51.6%), Au-Chit (46.4%) and Au-Cys (98.3%) and for 




degrees of DNA compaction could be unfavourable for transfection. Strongly associated pDNA 
enables the nanocomplex to safely transport its cargo to the cell but it becomes biochemically 
difficult when vector unpackaging is essential. On the other hand weak FAuNP/pDNA binding can 
trigger early dissociation resulting in degradation of the pDNA payload. Although, compaction and 
condensation of the DNA by all the nanoparticles was evident, from the results of the nuclease 
digestion studies where much of the DNA was degraded, suggests that the DNA may not have been 
very tightly complexed within the nanocomplex allowing access to the nucleases for some 
degradation to take place.  Furthemore the sharp decline in fluorescence (Figure 3.19) for almost all 
the nanocomplexes but more for the FAuNPs also suggests that the complexes may not be very 
stable. Although DNA compaction is not as tight as expected from the band shift assays, it is 
possible that when it comes to transfection the proton-buffering capacity of the polymers such as PEI 
will be stimulated thereby promoting gene expression and enhancing transfection. There was no 
direct correlation between the EtBr and retardation assays with regard to the end point. End point 
ratios determined in gel retardation assays indicated a minimum amount of FAuNP and CP that was 
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Figure 3.19: Ethidium Bromide intercalation assays of:  A) Au-PEI and PEI B) Au-Chitosan and Chitosan C) 
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3.4 In vitro cell culture assays 
3.4.1 Cell lines 
A four cell lines were successfully propagated in EMEM (with 10% FBS and antibiotics). Cells were 
monitored regularly with the required medium changes. Cells were trypsinized and plated for the 
various cell culture assays upon confluency. Of all the cell lines, the Caco2 cell line reached 
confluency much quicker and because the cells were in their mitotic phase they took up nutrients in 
the culture media very rapidly, requiring frequent replenishment of medium. 
    A                            B 
 
    C                   D 
 
Figure 3.20: The cell lines used for in vitro studies were A) HEK293 B) HeLa C) HepG2 D) Caco2.  Images 







3.4.2 In vitro MTT reduction assay  
Cytotoxicity is an important obstacle in the application of non-viral vectors for clinical gene therapy. 
In many cases a suitable surface modification may render toxic nanoparticles less harmless to allow 
application in medical therapy. The principle of the MTT assay lies in the formation of formazan by 
mitochondrial succinate-reductases in metabolically active cells, which determines mitochondrial 
activity (Figure 3.21). The cytotoxicty of the FAuNPs and CPs were investigated in the human cell 
lines HEK 293, HeLa, HepG2 and Caco2. 
 
 
Figure 3.21: Metabolism of MTT-dye (yellow) to MTT-formazan crystals (blue) by mitochondrial 
dehydrogenases in living cells: (http://www.slideshare.net/AnVanRompay/overview-of-3dhuman-skin-
reconstructed-models-for-irritation-and-corrosion-testing-by-an-van-rom) Accessed 18 Nov 2014. 
Since for most cell populations the total mitochondrial activity is related to the number of viable 
cells, this assay can be broadly used to measure the in vitro cytotoxic effects of nanoparticles in cell 
lines (Van Meerloo et al., 2011). Cytotoxicity was evaluated at weight ratios that include their sub, 
optimal and supra-optimal ratios as obtained in the gel retardation studies. The overall goal of this 
study was to evaluate the underlying cytotoxic effects of FAuNPs and the CPs. Results were 
expressed as the percentage of cell viability with respect to a control (100%) corresponding to 




(blue/purple) produced after the reduction of the MTT (yellow) (Figure 3.21). This was determined 
by obtaining the absorbance measurements of the DMSO solubilized formazan.  
The control contained cells that were not treated with the nanocomplexes and is assumed to represent 
100% cell viability. The maximum cell viability of functionalized nanocomplexes in HEK293 cells 
were, Au-PEI (95.4%); Au-Cys (84.8%); Au-PLL (74.9%) and Au-Chit (42.3%). In HeLa cells it 
ranged from, Au-PLL (104%); Au-Cys (98.1%); Au-PEI (94.9%) and Au-Chit (65.8%). In HepG2 
cells the percentage cell survival was as follows: Au-Chit (126%); Au-PEI (98.2%); Au-Cyst 
(92.5%) and Au-PLL (85.5%). The Caco2 cell line cell viability was, Au-Cys (91.8%); Au-PEI 
(76.7%); Au-PLL (73.5%) and Au-Chit (48.2%). Au-PEI coated nanocomplexes in HEK293, HeLa 
and HepG2 cells showed a high percentage of cell viability with more than 90% cell survival 
(Figures 3.22 and 3.23), while cell viability in the Caco2 cells were just above 70%. The Dunnett 
comparison test revealed no statistical significance for the PEI functionalized polymers (p>0.05). 
Considering the non-toxic properties of gold nanoparticles and their biocompatibility with polymers 
(Shukla et al., 2005) the Au-PEI displayed a much lower level of toxicity compared to the PEI 
polymer on its own. This can suggest that the use of functionalized gold can be a safe and relatively 
non-toxic vehicle for gene delivery as evidenced from its cell viability results. The PEI based 
nanocomplex did not produce very high cytotoxicity overall. Literature has noted that PEI on its own 
can exhibit some cytotoxicity (Kim et al., 2013), but upon complexation with gold, its cytotoxicity 
levels dropped.  
The FAuNPs were relatively non-toxic with survival rates above 60% except for the Au-chit where 
levels in the HEK293, Hela and Caco2 cells at certain ratios were below 60%. However, Au-chit 
significantly promoted cell growth up to 126% (p<0.01) in HepG2 cells. A possible explanation 
behind this may be that when the Au-Chit nanocomplexes interacted with the cell membrane it 
stimulated growth factors. This promotion in cell growth is a sign that the cells were healthy and 
maintained their morphology and adhesion capacity. Chitosan is also known to have good 
biodegradability and a high biocompatibility for cells and has been used in the development of 
controlled drug delivery systems (Rajam et al., 2011). It is not totally clear as to why it proved to 
have the lowest viability in the three cell lines mentioned as opposed to the liver cells. This could be 
due to the presence of receptors on the HepG2 cell surface that have high affinities for the 
carbohydrate moieties such as galactose and were stimulated by the chitosan particles.  Furthermore, 




In the HeLa and HepG2 cells the higher the AuCP/DNA ratio the lower the cytotoxicity observed as 
indicated by the high cell viabilities (Fig 3.22 B and Figure 3.23 A). These results indicated that the 
nanocomplexes have a dose dependent cytotoxic effect on the cell lines and that cell viability was 
enhanced with all gold incorporated nanocomplexes. 
Cells retained their viability over the 48 hour incubation period, and tolerated the gold 
nanocomplexes by encouraging cell growth as seen by the Au-PLL nanocomplexes in HeLa cells 
(p>0.05) and Au-Chit in HepG2 cells (p<0.01). In addition the cationic polymers on their own 
displayed a marked reduction in cell survival in some cell lines. This finding provides substantial 
evidence that across all four cell lines the FAuNps were relatively safe to administer. This is possibly 
because the polymers presented similar biochemical surface features as cells. The Caco2 cell line 
demonstrated significant stimulatory activity for all nanocomplexes (p<0.01). The importance of 
testing the safety and efficacy of gene nanovectors for cytotoxicity and biocompatibility is of crucial 
importance when developing biomaterials for in vivo applications. The MTT reduction assay 
confirmed that the FAuNPs used in this study are relatively safe and have good feasibility for future 










Figure 3.22: MTT cell viability assay in cell lines A) HEK293 and B) HeLa. Each column represents the 

















































Figure 3.23: MTT cell viability assay in cell lines A) HepG2 and B) CaCo2. Each column represents the 
mean ± SD (n = 3). *p<0.05 and **p<0.01 was considered statistically significant. For the Caco2 cell line all 


























































3.4.3 In vitro transfection studies 
The transfection of the four human cell lines HEK293, HeLa, HepG2 and Caco2, was assayed using 
the luciferase reporter gene assay (Promega). All cells displayed different tolerance levels to the 
nanocomplexes which may influence cellular uptake and hence transgene activity. The FAuNPs 
complexes exhibited an increased cellular uptake efficiency compared to the plain cationic polymers 
(Figure 3.24 and 3.25). Most of the nanocomplex assemblies showed variance throughout the cell 
lines. This was due to the difference in cell membrane properties (Callaghan et al., 1992 and 
Ruponen et al., 2004) and varied cell division rates which influenced nanocomplex cell membrane 
interaction and entry of pDNA into the nucleus (Zuhorn and Hoekstra, 2002). Each cell type also 
undergoes a different degree of electrostatic interaction with the nanocomplex producing variance in 
the cellular uptake efficiency of the different samples.  
As shown in figures 3.24 and 3.25 all four cell lines displayed an increase in transgene activity as the 
concentration of FAuNPs increased. They exhibited a relatively rapid uptake of these 
nanocomplexes. The MTT cytotoxicity results had showed that the maximum reduction in cell 
viability was observed at the lowest Au:CP ratio for all nanocomplexes irrespective of the cell line. 
The enhancing effect of gold can be seen by the general trend in gene expression, where an increase 
in FAuNP concentration was complemented by an increase in luciferase activity. The activity of the 
nanocomplexes seemed to be cell line specific, and hence consistent with MTT cytotoxicity results, 
with the FAuNPs exhibiting higher transfection activity compared to the plain CPs. This can also be 
correlated to the cytotoxicity assay. Another contributing factor to the increase or decrease in 
transfection activity is to correlate particle size and the positive surface charge of the nanocomplexes 
with the negative charge of the cell membrane. Surface charge is one of the several factors that 
influences the cellular uptake mechanisms of phagocytsis and pinocytosis, with the culture medium 
also being responsible for modifying the surface charge (Mahmoudi et al., 2011). Bearing in mind 
zeta potential is just an estimation of the surface charge and most importantly provides information 
on the stability of the nanocomplex in solution, the poor transfection efficiency of Au-Cys in 
HEK293 and Caco2 cells could be due to the agglomerated particles as seen by TEM analysis 
(Figure 3.16 F). Even though they revealed above 70% cell viability, the TEM images show large 
particles which may have effected their entry into the cell. Hence, there was low transfection because 
the particles, if and, when they entered the cells were most likely only localized in the cytoplasm.  
HeLa cells (Figure 3.24 B) revealed exceptional transfection activity (p>0.05) of 7.5 x 108 RLU/mg 




in the cysteine molecule stimulated the performance of gold as the delivery vehicle. In contrast using 
the unmodified cysteine resulted in no significant uptake (p>0.05). Gold incorporated polymers in 
the HeLa cell line (Figure 3.24 B) clearly enhanced transfection efficiency with regard to pDNA:Au-
PLL (1:3.5 w/w) and pDNA:Au-Cyst (1:41 w/w). There was an immense 5 fold increase in gene 
expression when the concentration of Au-PLL was increased from 1.68 µg to 1.76 µg. This was due 
to its favourable size of 130 nm as well as the positive zeta potential of 47.9 mV. HEK293 cells 
showed strong resistance to transfection by PEI:pDNA nanocomplexes overall. The Au-PEI 
nanocomplex in HepG2 cells revealed an astounding 12 fold increase (p<0.001) in gene expression 
at weight ratio 3 (1:12 w/w) of 1.6 x 107 RLU/mg protein, which was only increased by 0.5 µg from 
that of weight ratio 2 (1:10 w/w) at 1.3 x 106 RLU/mg protein. Since cell membranes are negatively 
charged and the Au-PEI nanocomplex is positive (53.8 mV), the superior enhancing effect of the PEI 
on gene expression was most likely due to its proton buffering ability. At this specified nanocomplex 
concentration we may predict that the endosome ruptured due to the osmotic pressure gradient and 
released the Au-PEI nanocomplex into the cytoplasm (Kim et al., 2013). The chemical interaction 
between PEI and gold may have also contributed to mechanical effectiveness of the nanocomplex as 
compared to the plain polymer.  
A possible reasoning to the low transfection in HepG2 cells could be due to the poor uptake of the 
nanocomplex and poor release of pDNA by the nanoparticle. Furthermore, there may have been 
degradation of the DNA by nucleases prior to its entry into the nucleus as was seen by the nuclease 
protection assay. The cellular dynamics at the time of cell growth may have also contributed to poor 
conditions for gene expression. HeLa cells (Figure 3.24 B) noticeably offered favourable cellular 
uptake compared to the HEK293 cells (Figure 3.24 A). Caco2 cells transfected by the Au-Chit 
nanocomplexes displayed the highest luciferase activity (p>0.05) and showed a 3 fold increase from 
ratio 1 (1:0.04 w/w) at 6.16 x 105 RLU/ mg protein to that of ratio 3 (1:0.16 w/w) at 1.8 x106 RLU /mg 
protein. The size of the nanocomplex was 186 nm and the zeta potential was 28.4 mV making it 
suitable for entry via the cell membrane. The second highest transfection efficiency was 
demonstrated by the Au-PEI nanocomplex with a 3 fold increase from weight ratio 2 (1:10 w/w) at 1.5 
x 106 RLU/mg protein to weight ratio 3 (1:12 w/w) at 5.7 x 105 RLU/mg protein.  The Au-PEI 
nanocomplex presented a size of 217 nm and a zeta potential of 53.8 mV. This was the highest zeta 
potential from all the samples and not only provided stability to the nanocomplex en route to the 
nucleus, but due to its positive surface charge gave rise to an electric field that attracted counter ions 
into the endosome. Consequently it also exhibited high transfection activity across all four cell lines. 




microenvironment and due to its higher concentration they are easily internalized in cancer cells 
(Crayton and Tsourkas, 2011). Interestingly it is important to note that a similar trend is noticed 
throughout the nanocomplex assemblies in the Caco2 cell line where an increase in ratio from 1 to 2 
did not produce a difference, but when the ratio increased from 2 to 3 so did the level of transfection 
change quite distinctively.  
Perhaps it is safe to speculate from previous research (Balbino et al., 2012) that the dose dependent 
concentration of the nanocomplexes here induced saturation of the vesicles retaining pDNA and 
could have led to generation of new nanocomplex structures of the gold functionalized particles that 
elevated larger particles for gene expression. It is important to note that the Caco2 cells were actively 
dividing and this phase of cell division could have led to the impressive and consistent cellular 
uptake and expression. Caco2 cells also did not seem to tolerate nanocomplexes as well as the other 
3 cell lines studied (Fig 3.23 B). Though positive complexes are found to be necessary for absorption 
onto the negatively charged phospholipid cellular membrane and optimum transfection, their positive 
















Figure 3.24: In vitro transfection activity in a) HEK293 and b) HeLa. Each column represents the mean ± SD 
(n = 3). Gene expression activity was measured in RLU/mg protein. ***p<0.001, **p<0.01 and *p<0.05 were 
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Figure 3.25: In vitro transfection activity in c) HepG2 and d) Caco2. Each column represents the mean ± SD 
(n = 3). Gene expression activity was measured in RLU/mg protein. ***p<0.001, **p<0.01 and *p<0.05 were 
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Chapter Four  
Conclusion and future work 
Numerous non-viral gene delivery systems have been developed over the last two decades, however, 
therapeutic applications of these systems are rather limited despite their progress in vector design. To 
improve currently available systems and to develop new methods of gene delivery, continuous effort 
is needed that could lead to safer and more efficient non-viral gene-delivery. AuNPs present versatile 
synthetic scaffolds for efficient delivery of drugs and biomolecules. Cationic lipids and other 
naturally occurring compounds have proven to be effective for in vitro gene delivery, yet all of these 
cationic molecular based systems have shown to be unimpressive or have not to date been  successful 
in clinical trials. The proposed way forward was the use of FAuNPs, because the combination of 
their low inherent cytotoxicity, photoluminescence properties, high surface area and tunable surface 
chemistry could prove favourable in gene delivery. This has contributed to their growing application 
in clinical practice. The outcomes herewith mentioned, hint at the potential of FAuNPs in both in 
vitro and future in vivo applications.  
This thesis covered preliminary studies on the synthesis and electrokinetics of gold nanoparticles 
functionalized with the amino acid lysine and cationic polyelectrolytes, PEI and PLL, prior to 
looking at their biological activities in vitro. The use of L-lysine functionalized gold nanoparticles 
was discontinued since L-lysine exhibited positive electrophoretic mobility predominantly at pH 3, 
with binding at pH 7.4 and at neutral pH showing fairly weak complexation of L-lysine to gold and 
to plasmid DNA. Studies were further conducted with polymers, PLL, PEI, cysteine and chitosan.  
One of the disadvantages of gene delivery applications is the size of the nanocomplex. In general 
poor sizes and binding affinities of negatively charged nanocomplexes promote the formation of 
large aggregates that hinder entry via the cell membrane and can accumulate leading to cytotoxicity. 
We have successfully demonstrated the functionalization of gold nanoparticles using polymers (PLL, 
PEI, cysteine and chitosan) which degrade through different mechanisms. Some of the advantages of 
these FAuNP complexes, include their relatively stable and small sizes as seen in TEM images and 
zeta sizing, their successful pDNA binding ability as evidenced by the band shift assay, their pDNA 
condensation properties (EtBr dye displacement assay) and their partial protection of pDNA cargo in 
the nuclease digestion assay. Furthermore, we have shown that these nanocomplexes were well 
tolerated by all the human cell lines studied. This has added to the overall understanding of the 




to FAuNPs which was shown to be limited if any in vitro.  Furthermore, the FAuNP complexes 
exhibited higher cell viability in a dose dependent fashion compared to the corresponding CP 
complexes. Au-PEI, Au-PLL, Au-Cys and Au-Chit complexes all promoted cell growth while Au-
Chit showed the highest viability of 126% (p<0.01) and hence food growth promoting properties. 
The best performing nanocomplex was Au-PEI/pDNA that displayed consistently high cell viability 
(80%) across all four cells lines. Au-cys on the other hand exhibited significantly high cell viability 
of 91.8% in the colorectal cancer (Caco2) cells (p<0.01).  Cytotoxicity also seemed to be cell 
specific with some cells showing greater tolerance to specific nanocomplexes. This cytotoxic study 
has yielded significant data which could be used in future research. However, not all FAuNP 
complexes that yielded high cell viability produced the corresponding high transfection results. The 
determination of transfection using the luciferase reporter gene assay showed good transgene activity 
in the human cell lines investigated. Transgene activity for the Au-PEI/pDNA complexes showed a 
12 fold and a 9 fold increase (p<0.001) over that obtained with its corresponding CP (p<0.001) in the 
HEK293 cells and HepG2 cells respectively. This high transfection activity of Au-PEI complexes 
correlated to its cell viability where it achieved over 95% cell viability in both cell lines. The 
noticeably high gene expression of Au-PEI/pDNA in HEK293 and HepG2 indicated that these cell 
lines were able to take up the Au-PEI/pDNA nanocomplexes readily, and further allow for safe and 
efficient intracellular trafficking.  PEI on its own is generally regarded as being toxic to cells, 
however, as seen from our studies its combination with Au nanoparticles has led to improved 
cytotoxicity and gene expression. 
The results strongly suggest that these nanocomplexes demonstrate the potential for being efficient 
gene delivery vectors in vitro compared to their CP counterparts, possibly due to the electrokinetic 
stability of the gold core. The FAuNPs were however varied in their efficiency with Au-PEI>Au-
PLL>Au-Cys Au-Chit. Based on the results obtained it can be proposed that the mechanism of 
cellular uptake of the  FAuNPs  is different for the different classes of  FAuNPs across the four cell 
lines, which may involve the activation of  different sets of proteins and or cell surface receptors. 
This could follow from the diverse modifications of the AuNPs using the different CPs that allowed 
for the modulation of various physiochemical properties.  
Future work could include the investigation of other combinations of CPs with the AuNPs and other 
possible transfection methods such as sonoporation and laser irradiation to control the release of 
genes before in vivo trials are strictly explored. Furthermore, the attachment of targeting ligands for 
cell specific targeting, and PEG for nanoparticle shielding in circulation are options for further 




nanoparticles is that it can be tracked by imaging which is becoming a very important diagnostic tool 
in medicine. The accurate mechanisms of cellular uptake of FAuNPs should however be identified to 
facilitate optimization of them as platforms for efficient internalization. Considering the immense 
interest today in gold nanoparticles, this process may soon be elucidated. 
In summary these functionalized gold nanoparticles were able to efficiently bind and deliver pDNA 
to three cancer (HepG2, HeLa and Caco2) and one normal cell line (HEK293) in vitro. Preliminary 
results do suggest the need for these complexes to be tested further in a range of mammalian cells to 
confirm and establish further their cytotoxicity, cell specificity and stability in order to eventually 
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a  b  s  t  r  a  c  t
Gold  nanoparticles  have  attracted  strong  biomedical  interest  for  drug  delivery  due  to their low toxic
nature,  surface  plasmon  resonance  and  capability  of increasing  the  stability  of the  payload.  However,
gene  transfection  represents  another  important  biological  application.  Considering  that  cellular  barri-
ers  keep  enclosed  their  secret  to deliver  genes  using  nanoparticles,  an  important  step  can  be  achieved
by  studying  the  functionalization  of  nanoparticles  with  DNA.  In the  present  contribution  the  synthe-
sis  of nanoparticles  consisting  of a  gold  core  coated  with  one  or more  layers  of amino  acid  (l-lysine),
and  cationic  polyelectrolytes  (poly-ethyleneimine  and  poly-l-lysine)  is reported.  All  nanoparticles  were
subjected  to  dynamic  light  scattering,  electrophoretic  mobility  measurements,  UV–vis  optical  spectro-
photometry  analysis  and  transmission  electron  microscopy  imaging.  In addition,  the  adsorption  of  DNA
plasmid  (pSGS)  with  linear  and  supercoiled  configurations  was  studied  for those  gold  nanoparticles  under
the  most  suitable  surface  modifications.  Preliminary  results  showed  that  the  gold  nanoparticles  function-
alized  with  poly-ethyleneimine  and  poly-l-lysine,  respectively,  and bound  to linear  DNA  configurations,
present  in  absolute  value  a higher  electrophoretic  mobility  irrespective  of the pH of the  media,  compared
to  the  supercoiled  and  nicked  configuration.  The  findings  from  this  study  suggest  that  poly-ethyleneimine
and  poly-l-lysine  functionalized  gold  nanoparticles  are  biocompatible  and  may  be  promising  in  the  chem-
ical  design  and  future optimization  of nanostructures  for biomedical  applications  such  as  gene and  drug
delivery.. Introduction
Gold nanoparticles (AuNPs) have sparked much interest in the
elds of chemistry, physics, biology, medicine and biomaterial sci-
nces. They are bioinert, non-toxic and readily synthesized [3] and
heir small size allows them to penetrate cells and tissues, making
heir application in medicine far reaching. They have become one
f the most interesting sensing materials because of their unique
ize and shape dependent optical properties, high extinction
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coefficient and super-quenching capability. AuNPs hold the
promise for efficient gene or drug delivery into cells by absorbing
and resonantly scattering visible and near-infrared light upon exci-
tation of their surface plasmon-oscillation [14]. AuNPs do not have
target recognition abilities necessary for selective binding of ana-
lytes of interest. In order to selectively detect analytes of interest
antibodies, short-chain organic acids, proteins or DNA molecules
have been used to modify the surface properties of AuNPs to
provide target recognition sites [20]. These molecules can be incor-
porated into AuNPs through electrostatic attraction or covalent
bonding. It is an effective way to enhance specificity and efficacy of
nanoparticle based delivery systems [17]. For them to be success-
fully utilized in medical applications their fundamental properties
such as the forces that are responsible for nanoparticle-drug stabi-
lization must be understood.
AuNPs  are also currently being used as delivery vehicles to



























































26 G.G. Lazarus et al. / Colloids and Surf
ithout significant cytotoxicity. They demonstrated high stability
nd effective transfection in multiple myeloma cells ([8] and [2]).
hese particles can also be carriers of peptides and proteins. They
resent strategies for the treatment of genetic as well as acquired
iseases. The release of gold nanoparticles is vitally important for
ffective therapy. This release could be triggered by internal (e.g.
luthathione), pH or external stimuli such as light [6].
Electrokinetic characterization was carried out first, because
n order to design a carrier, one needs to know the features and
roperties of the system that one is working with. These include
ydrophobicity/hydrophilicity, size and most importantly charge.
t is important to note that each time the surface of a nanopar-
icle is functionalized, any one of these (or all three at the same
ime) properties may  change. Adsorption on the surface commonly
esults in a modification of the charge. Therefore electrophoretic
obility (Ue) studies were carried out to determine and optimize
he preparation conditions of the final surface charge. Complemen-
ary to this feature, dynamic light scattering was also performed
n order to confirm the surface modification of the nanoparticle
ith an external agent. Size and surface charge of DNA complexes
re two important factors in determining the efficiency of cellular
ptake. Although there is a common theme in all vectors, each vec-
or has to be suitably tailored and optimized to meet the needs of
 specific application.
This  was seen when attaching a functional group such as lysine
o a nanoparticle, the pKa values (2.2, 8.5, and 10.28) had to be con-
idered in order to determine at which pH this amino acid needed
o be prepared. Depending on the physical orientation of its side
hains, lysine may  form bridges with the citrate ions enclosing
he AuNP and resulting in aggregation. This may  account for the
egative or decreased electrophoretic mobility observed. Lysine
ontains 1 carboxylic group and 2 amine groups so a fully pro-
onated lysine molecule has a +2 net charge. The two -amino
roups have pKa’s of 9.0 and 10.2 respectively which are signifi-
antly higher.
.  Materials and methods
Water  (Milli-Q Academic, Millipore, France) was  used in
he preparation of all suspensions. Gold(III) chloride trihydrate,
risodium citrate dehydrate, ethanol, l-lysine, polyethyleneamine
PEI branched, 25 kDa) and poly-l-lysine (PLL) were purchased from
igma Aldrich. Citric acid was from Pancreac (Spain). All chemicals
ere of analytical quality. DNA plasmid pSGS was amplified at Hos-
ital Universitario San Cecilio, Granada. The following instruments
ere used. Nanosight Nanoparticle Tracking Analysis (NTA) Ver-
ion 2.2 Build 0377, Zetasizer Nanoseries Nano-ZS Model ZEN 3600
Malvern Instruments, U.K), Eppendorf Centrifuge 5418, NanoDrop
000c spectrophotometer (Thermo Scientific, Wilmington, USA),
ettich Zentrifugen Mikro ZZ0R, Gel electrophoresis apparatus,
H meter, Perkin Elmer Lambda 20 UV–vis spectrophotometer,
ransmission electron microscope Jeol (T 1010), iTEM Soft Imag-
ng Systems (SIS) MegaView III side-mounted 3 megapixel digital
amera.
.1. Synthesis of colloidal gold nanoparticles by citrate reduction
0.45  × 10−3 M of an aqueous colloidal gold solution was  pre-
ared by HAuCl4 reduction with sodium citrate using the method of
18]. A solution consisting of 0.11 mL  gold colloidal in 25 mL  water
as boiled for 15 min  and thereafter 1 mL  of 1% sodium citrate wasdded rapidly to the vortex of the solution. On addition of the citrate
nto the boiling tetrachloroaurate solution the colour changed from
ale yellow to dark blue within the first 3 min  and then ruby red
fter 15 min  of reaction time. It was boiled for a further 5 min  on: Biointerfaces 121 (2014) 425–431
the  heating mantle, thereafter removed and left to cool down to
room temperature. It was  stored in a dark bottle.
2.2. UV–vis optical spectrophotometry analysis
The qualitative analysis in particle uniformity and stability of
each gold nanoparticle was followed up by examining the absorp-
tion spectra of the individual nanoparticles and to confirm in
agreement with literature that the expected SPR absorption of the
nano-sized gold particles occurs at 534 nm.  UV–vis absorption mea-
surements were conducted and the spectra recorded by measuring
dilute samples in a quartz cell with a path length of 1 cm.
2.3. TEM and size analysis
The  morphology of gold nanoparticles was observed by TEM.
The zeta potentials and mean sizes of the gold nanoparticles were
analyzed using a Zetasizer. The zeta potential measurements were
performed in triplicate at pH 7.
2.4. Functionalization with amino acid and cationic
poly-electrolytes
Different concentrations of the amino acid lysine (0.01, 0.1, 5,
10, 100, 200 and 500 mg/mL) and cationic poly-electrolytes; poly-
l-lysine (1, 5, 10 and 100 mg/mL) and poly-ethyleneimine (1, 10
and 100 mg/mL) were prepared by dissolving the required amount
into water according to the desired pH. Adsorption was carried
out by slowly adding the gold colloidal solution dropwise to each
amino acid and poly-electrolyte solution under constant and mod-
erate vortexing. They were washed three times to remove any free
polyelectrolytes that remained in solution.
2.5. Electrokinetic characterization
Zeta  potential is a powerful tool that is used to analyse the
electrostatic forces within the bulk solution and on the surface of
the nanoparticles and nanocomplexes, respectively [15]. One drop
of the gold suspension coated by the respective amino acid and
poly-electrolyte as described in Section 2.4, was added to 10 mL
of an aqueous solution of respective pH 3–9 and desired ionic
strength. After 24 h of incubation, the pH was re-adjusted and
the electrophoretic mobility was  measured. Citric acid and sodium
hydroxide were used to adjust the pH.
2.6. Ionic strength studies
Ionic  strength studies were performed to determine the com-
pactness of the adsorbed layer. To achieve this we investigated
the effect of electrolyte concentrations on the Ue. Essentially in the
presence of layers the mobility should tend towards zero because
of the electric double layer compression at high ionic strength.
The dispersion medium, sodium chloride, was prepared in dif-
ferent ionic salt concentrations of (1 × 10−4; 1 × 10−3; 2.5 × 10−3;
5 × 10−3; 7.5 × 10−3; 1 × 10−2; 2.5 × 10−2; 5 × 10−2 mg/mL).
3.  Results and discussion
3.1.  Gold nanoparticle synthesis by citrate reductionThe transition in colour of the AuNPs from pale yellow to ruby
red confirmed the formation of citrate-capped gold nanoparticles
[18]. When the pale yellow colour fades it signifies the formation
of the gold atoms which nucleate to form dark red nanowires. The
G.G. Lazarus et al. / Colloids and Surfaces B




























and lysine has an overall +2 net charge (Fig. 1). Therefore there isWavelength
Fig. 2. UV–vis spec of Au and Au-Lys NP (100 mM).
anowires destabilize with an increase in size followed by frag-
entation and cleavage to form the citrate-capped AuNPs.
.2.  UV–vis spec
Figs.  2 and 3 show the UV–vis absorption spectra and TEM
nalysis, respectively, of the citrate-reduced colloidal nanoparti-
les synthesized. The surface plasmon resonance (SPR) absorption
f the nanoparticles was observed at 534 nm.  This is in agreement
ith the expected SPR absorption of the nanosized gold particles
t this wavelength. The absorption of lysine onto the surface of the
old particle was confirmed by a decrease in the absorbance peak
o 519 nm.  A blue shift can be observed by the decrease in wave-
ength which denotes a decrease in particle size. Size and shape
f the nanoparticles is of major importance to the efficiency of
Fig. 3. Transmission electron microscopy analys: Biointerfaces 121 (2014) 425–431 427
cellular  uptake in transfection studies. From the TEM micrographs,
the nanoparticles appear spherical with a smooth shape and sur-
faces that are homogenous in the nano-sized range of 30–50 nm.
Subsequent observations showed no structural modifications such
as aggregation or absorption changes for the particles after 6
months at room temperature.
3.3.  Electrophoretic mobility measurements
3.3.1. Effect of pH and concentration of cationic functional groups
PEI and PLL were used to investigate their interaction and rela-
tionship with gold nanoparticles and to determine whether gold
may reduce its toxicological effects. The AuNP’s were combined
with PEI to prepare (1, 2, 5, 7 and 10 mg/mL) of PEI-coated AuNP’s
and PLL (1, 10 and 100 mg/mL) of PLL-coated AuNP’s. PEI displayed
sizes in the range 70–120 nm (Fig. 5b) which is more acceptable
compared to PLL 350–500 nm (Fig. 5a). Au-Lys-PEI nanoparticles
were coupled to DNA of 3 different isophorms. The DNA conju-
gates with the nanoplexes were found to be positively charged
with a considerable increase in particle size. Fig. 4a and b shows
the electrophoretic mobility of Au-PLL and Au-PEI as a func-
tion of its concentration in solution. The results obtained show a
considerable increase in electrophoretic mobility of the cationic
functionalized groups when adsorbed onto gold nanoparticles. The
increase in electrophoretic mobility is due to the cationic charac-
ter of both polymers. In the case of poly-l-lysine the higher the
concentration the greater the positive charge. Note in the case of
polyethyleneimine for the concentration range studied, the gold
nanoparticles were already close to the saturation region predicted
in the law of Lambert Beer. It was not necessary to prepare the Au-
PLL and Au-PEI complexes at varying pH’s as they are positively
charged entities.
Lysine  exhibited positive electrophoretic mobility predomi-
nantly at pH 3 (Fig. 6). This correlates to previous literature [19].
The researchers investigated the adsorption of amino acids onto the
surface of magnetite cores by measuring the electrophoretic mobil-
ity of the amino acid-coated magnetite particles and comparing the
results with the ones obtained for the unmodified magnetite cores.
Likewise in order to explain lysines’ particular pH dependence and
its effect on Ue, we coated the gold nanoparticles with lysine and
took into consideration the pKa of its ionized groups. Lysine has
pKa values of 2.2; 8 and 10. At pH 3 the Au-lys NP’s are protonatedattraction and adsorption between the two particles. The isoelectric
point with minimum electrostatic repulsion, shifted 4 units back
(pH 3) from the norm (pH 7) after the gold was  put into contact
is of AuNP at (a) 40 000× and (b) 60 000×.




















































































Fig. 5. (a) Zeta sizing by dynamic light scattering of Au-PLL and (b) Au-PEI as a
ith lysine. At pH 7 the Ue is negative because the lysine bound to
old forms cross bridges with each other resulting in aggregation
Fig. 6). As the pH increases to 9, deprotonation occurs, hence the
egative Ue. The Au-Lys NP experiences repulsion, resulting in little
r no adsorption taking place.
The difference in pH trend was further studied by modifying
he surface adsorption of the AuNP and varying the concentration
f lysine in solution. As a result, at low lysine concentrations of
.01 and 0.05 mg/mL  the values correspond to the bare gold parti-
les. In Fig. 6 there is a distinct adsorption on the bare AuNP with






























ig. 6. Electrophoretic mobility (Ue) of Au-lys as a function of pH. Error bars repre-
ents  the mean ± SD, n = 3.PEI concentration (mg/mL)
ion of its concentration in solution. Error bars represents the mean ± SD, n = 3.
irrespective of pH. This again can be attributed to the fact that
at high pH lysine is deprotonated and any further increase in
the concentration of lysine in solution leads to saturation of the
AuNP resulting in cross-binding, aggregation and negative mobil-
ity (Fig. 7a). The size distribution (Fig. 7b) by intensity correlates
to the size by zeta sizing. This is evident by the colour changes of
the nanocomplex in solution (Fig. 8a). It shows a distinct change
from red to purple. It is likely that an increase in lysine concen-
tration may  have caused bridging leading to aggregation. At the
lowest concentration of lysine (1–5 mg/mL) the colour is a ruby
red. Red is indicative of small particles of 20–40 nm in size. After
24 h the Au-lys of small size (Fig. 8b and c) turned purple indi-
cating aggregation and instability. As the concentration of lysine
was increased (6–10 mg/mL) the colour changed to a deeper pur-
ple which indicated the formation of clusters and larger particles
around 70–80 nm.
3.3.2. Au-Lys-PLL and its interaction with DNA
Nanoparticle binding can facilitate DNA compaction in addition
to partial strand separation [5]. We  did not incubate the Au-Lys NP
with DNA because lysine was  positive only at pH 3 which is too
acidic for the body to optimally function in. The pH of blood is 7.4
and in order for the nanocomplexes to circulate in the body it has
to be neutral or slightly positive. Although PEI revealed size distri-
butions within our desired size range and positive electrophoretic
mobility, PEI was  not employed further with DNA plasmids since
previous literature had shown some toxicity to cells. Hence fur-
ther studies with Au-PLL were conducted and Au-PLL incubated
with DNA pSGS. It exhibited size distributions in the range of
G.G. Lazarus et al. / Colloids and Surfaces B: Biointerfaces 121 (2014) 425–431 429












Fig. 8. (a) Colour changes of AuNPs after addition of lysine at varying concen
10–290 nm (Fig. 9a). As the concentration of PLL was  increased the
NA strands wrapped tighter around the Au-PLL complex thereby
ompacting it as seen in the TEM images (Fig. 10) with a size
ecrease of more than 50% (Fig. 9a). Given that the smallest particle
ize is at 10 mg/mL, the Au-PLL NP that was prepared accordingly
nd incubated with DNA pSGS of different isophorms as a func-
ion of their concentration. The results obtained (Fig. 9b) indicate
hat the Ue of linear and supercoiled isophorms tended towards
ig. 9. (a) Size distribution of Au-PLL and DNA pSGS as a function of PLL concentration a
epresents the mean ± SD, n = 3.ns (0.1, 5, 10, 100, 200 and 500 mg/mL); (b) Au-Lys and (c) Au-Lys after 24 h.
zero.  When supercoiled DNA was complexed to PLL it yielded a
much lower effective negative charge than linear DNA since the
polyelectrolyte is compacted with a large amount of counter ions.3.3.3. Effect of ionic strength
The  results show that at high ionic strength electroneutrality
was achieved, this can be interpreted to mean that the electric dou-
ble layer was  compact and stable. When the surface of the gold core
nd (b) Ue of Au-PLL and DNA pSGS as a function of DNA concentration. Error bars
430 G.G. Lazarus et al. / Colloids and Surfaces B: Biointerfaces 121 (2014) 425–431

















































[5] P.S. Ghosh, C. Kim, G. Han, N.S. Forbes, V.M. Rotello, Efficient gene deliveryig. 11. Ue of Au-PLL, Au-PEI and its interaction with supercoiled DNA as a function
f ionic strength. Error bars represents the mean ± SD, n = 3.
as covered by PLL-DNA and PEI-DNA (Fig. 11), the particles did
ot display soft electrokinetic behaviour. Using the formalization
erived by [16] which is in turn based on the complexation the-
ry recently developed by [10,11], it describes the complexation
f long polyelectrolytes with oppositely charged spherical bodies
o a single negative molecule of DNA. The theory predicts that in
 system, equilibrium is reached by the DNA concentration with
ipoplexes. The same can be said for metal nanoparticles which
llows us to predict the isoelectric point where the nanocomplex
s almost neutrally charged [15].
. Conclusion
We  described the synthesis and electrokinetics of gold
anoparticles functionalized with amino acid lysine and cationic
olyelectrolytes, poly-ethyleneimine and poly-l-lysine. In view of
revious applications of lysine functionalized gold nanoparticles,
e report findings that at predominantly high concentrations of
ysine there is only a slight increase in negative electrophoretic
obility. Lysine exhibited positive electrophoretic mobility pre-
ominantly at pH 3, which correlates to previously published
iterature [19]. However required binding of lysine at pH 7.4 and at
eutral pH show that the complexation of lysine to gold is fairly
eak as confirmed by [7]. Since positivity was not achieved at
igh lysine concentrations and hence no DNA interaction, further
inding studies were not conducted.
With regards to PEI, it displayed strong positive Ue (Fig. 4b) com-
ared to PLL, with favourable size distributions due to compactionng aggregates (b) Au-Lys DNA complex.
with  DNA. The Ue tended towards zero, meaning the overall surface
charge was  neutral which is required for further use in transfection
studies. At high ionic concentrations the Ue tended towards zero
owing to the electric double layer, confirming a compact molecule
([4,12]). Ref. [13]recently revealed that when the isolelectric point
is reached in a system an inversion of electrophoretic mobility
sign takes place. This behaviour was previously found in works of
cationic lipoplexes. In this study no charge inversion was reported
at the desired concentration. This means that within the concen-
tration range the gold nanoparticles neutralized the charge of DNA
in the system. This may  be due to the different and unique prop-
erties of gold nanoparticles compared to liposomes. In accordance,
Ref. [9], confirms the significance of the isoneutrality point which
is defined as the ratio at which the positive charge of the lipo-
somes, which in our study is the cationic coated gold nanoparticle
that neutralizes the negative charge coming from the phosphate
group of DNA. This makes it a potential cell transfecting agent. It
was observed that when supercoiled, linear and nicked DNA were
complexed to PLL respectively, supercoiled DNA  yielded a much
lower effective negative charge than linear and nicked DNA. This
is confirmed with results recently published by Barran-Berdon and
co-workers in 2012. In summary PLL functionalized AuNPs show
promising characteristics for use as a non-viral gene delivery sys-
tem. In vitro cytotoxicity and transfection studies in mammalian
cells are currently being conducted.
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